The Applicability of a Short-term Test for Detection of Modifying Effects of Dietary Factors in Rodent Colon Carcinogenesis by Kristiansen, Eva
THE APPLICABILITY OF A SHORT-TERM TEST FOR 
DETECTION OF MODIFYING EFFECTS OF 
DIETARY FACTORS IN RODENT COLON 
CARCINOGENESIS 
Ph.D. Thesis 
Eva Kristiansen 
Institute of Food Safety and Toxicology 
Danish Veterinary and Food Administration 
and 
Institute of Life Sciences and Chemistry 
Roskilde University Center 
Denmark 
DATA SHEET 
Title: 
Author: 
Publisher: 
Department: 
Address: 
Telephone: 
Fax: 
Abstract: 
Key words: 
The Applicability of a Short-term Test for Detection of 
Modifying Effects of Dietary Factors in Rodent Colon Carci- 
nogenesis. 
Eva Kristiansen. 
Danish Veterinary and Food Administration. 
Department of General Toxicology, Section for Pathology, 
Institute of Food Safety and Toxicology. 
Morkhoj Bygade 19, DK-2860 Soborg, Denmark. 
+45 33 95 60 00 
+45 33 95 66 96 
The present studies were initiated to develop a short-term 
rodent model to assess the influence of different dietary 
components on the development of colon cancer. 
Diets with different dietary components, i.e. dietary fibre, fat, 
sucrose, and starches were tested in male rats initiated with 
DMH-2HCl or AOM for their modulating effect on the 
development of aberrant crypt foci (ACF). Furthermore the 
heterocyclic amines IQ and PhIP were introduced in the assay 
as inducers of ACF in mice and rats and their role in colon 
carcinogenesis in mice was investigated. 
ACF were found to be induced in rodent colon by the colon 
carcinogens DMH-2HC1, AOM, IQ, and PhIP and it was 
shown that the incidence of the induced ACF could be 
modulated by dietary components such as sucrose, dietary 
fibre, and starch. 
Aberrant crypt foci, ACF, colcn cancer, dietary modulators, 
DMH-2HC1, AOM, IQ, PhIP, rat, mice. 
Please quote: Eva Kristiansen (1997): The applicability of a short-term test 
for detection of modifying effects of dietary factors in rodent 
colon carcinogenesis. Ph.D. Thesis. Danish Veterinary and 
Food Administration. DK-2860 Soborg, Denmark. 
ISBN: 87-601-2005-3 
Front cover: Illustration of the suggested relation between normal crypts, 
aberrant crypts, ACF, adenomas and adenocarcinomas. 
1: Normal crypts, 2: Aberrant crypt focus, 3: Adenoma, 
4: Adenocarcinomas. 
Drawn by Bent Vismann 
PREFACE 
The present studies constitute part of the research on the relation between 
diet and cancer at the Danish Veterinary and Food Administration. 
The aim of the studies presented here was to develop a short-term animal 
model to assess the influence of different dietary components on the 
development of colon cancer. The biomarker selected for the short-term 
assay should be a putative preneoplastic change that took place in the colon 
mucosa prior to the development of recognizable colon cancer, and hence 
should provide an alternative to the testing of dietary modulators without 
using cancer as endpoint. 
I wish to thank professor Ole Andersen, Institute of Life Sciences and 
Chemistry, Roskilde University Center, Denmark, for being my supervisor 
and for his interest and fruitful comments during the writing phase. Otto 
Meyer, Head of Biological Section, Institute of Food Safety and Toxicology, 
Danish Veterinary and Food Administration, is thanked for being my 
adviser, and, together with Inger Thorup, DVM, are thanked for many 
stimulating years of collaboration in the field of colon cancer research. 
Lejf Burkal, Head of the Animal Unit, together with the animal technicians 
are thanked for excellent management of the rats and mice, and Margareta 
Bertram for her skilful technical assistance. Especially, I wish to thank 
Merete Lykkegaard and Heidi Rokkedahl for their excellent laboratory work 
and never failing enthusiasm and for their encouraging and pleasant 
collaboration through the years. Finally I want to thank Bent Vismann for 
the drawings. 
Soborg, August 1997 
Eva Kristiansen 
CONTENTS 
SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
SUMMARY IN DANISH (SAMMENDRAG) . . . . . . . . . . . . . . . . . . 3 
LIST OF PUBLICATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
ABBREVIATIONS . . . . . . . . . . . . . . . ..I.................. 6 
INTRODUCTION ..................................... 7 
Epidemiology of colon cancer ........................ ? 
Experimental colon cancer .......................... 8 
Short-term assay for colon cancer ..................... 8 
DESCRIPTION OF THE SHORT-TERM ASSAY ............. 10 
Normal colon crypts ............................. 10 
Colon cancer inducers ............................ 11 
Carcinogen-induced changes in the crypts ............... 12 
Aberrant colon crypts ............................. 12 
OWN INVESTIGATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . 18 
A. 
B. 
C. 
Detection of ACF in colons from rats with 
carcinogen-induced tumours (Paper I) . . . . . . . . . . . . 18 
Modulating effect of different diets on the 
development of ACF and colon tumours in rats 
induced by DMH-2HCl or AOM (Paper II and III) . . . 19 
The heterocyclic amines 2-amino-3-methyl- 
imidazo[4,5-fiquinoline (IQ) and 2-amino-l- 
methyl-6-phenyl-imidazo[4,5-blpyridine (PhIP) 
in the ACF assay (Paper IV, V and VI) . . . . . . . . . . . 20 
RESULTS. ........................................ 21 
A. Paper I .................................. 21 
B. Paper II and III ............................ 22 
C. Paper IV, V and VI ......................... 22 
DISCUSSION ....................................... 23 
Study design ................................... 24 
Rodent species and strain/stock ...................... 25 
Dietary fibre ................................... 26 
Fat .......................................... 26 
Refined carbohydrates ............................ 26 
Starch ....................................... 27 
Colon cancer inducers of dietary relevance .............. 28 
Choice of initiator ............................... 31 
CONCLUSION ...................................... 32 
REFERENCES ...................................... 33 
APPENDIX ........................................ 48 -_ 
TABLE 1 ..................................... 49 
TABLE2 ..................................... 50 
TABLE3 ..................................... 52 
TABLE4 ..................................... 53 
OWN REFERENCES . 
PAPER I . . . . 
PAPER II . . . . 
. . 
. . 
. . 
. . 
. . 
. . 
.......................... 54 
. ......................... 55 
.......................... 62 
PAPER III .................................... 72 
PAPERIV .................................... 78 
PAPER V ..................................... 84 
PAPER VI .................................... 90 
SUMMARY 
Colon cancer is one of the most frequent types of cancer in humans, and 
epidemiological studies have indicated that the incidence of colon cancer is 
linked, in large measure, to the composition of the diet. 
Many of the alterations seen in human colonic mucosa during colon cancer 
development are also found in animal models. The cost and duration of 
traditional long-term animal studies with the endpoint cancer makes the 
screening for dietary modulators of colon cancer almost infinite. Therefore, 
short-term bioassays are recognized as being increasingly vital to this 
screening process. 
The presented studies were initiated to find an intermediate biomarker which 
could be used in a short-term assay for screening of dietary modulators of 
colon carcinogenesis. 
The intermediate biomarker chosen for the studies was a histological 
biomarker, the aberrant crypt foci (ACF). ACF are morphological lesions 
identified topographically in intact Giemsa stained colons, without being 
embedded in paraffin and sectioned. 
Different diets, high in fat, dietary fibre, starches or sucrose were investi- 
gated in the ACF assay in male rats initiated with the model colon 
carcinogens 1,2dimethylhydrazine dihydrochloride (DMH-2HCl) or azoxy- 
methane (AOM). A modulating effect on the DMH-2HCl- or AOM-induced 
ACF was detected with a dietary fibre, starch and sucrose. In general the 
most consistent finding was an effect on the total number of ACF and the 
number of small (l-3 crypt/focus) ACF. The studies which proceeded to 
tumour development did not show a clear relation between the outcome of 
ACF and tumours with any of the dietary components tested. 
The heterocyclic amines, 2-amino-3-methyl-imidazo[4,5-flquinoline (IQ) and 
2-amino-l-methyl-6-phenyl-imidazo[4,5-blpyridine (PhIP), were found to be 
able to induce ACF in both mice and rats, and in rats the incidence of ACF 
could be modulated by a diet high in sucrose. The effect was, like for DMH- 
2HCl and AOM, seen in the total number of ACF and the number of small 
(l-3 crypt/focus) ACF. Even though IQ and PhIP are not known to be colon 
carcinogens in mice, ACF were detected in mice after both short-time and 
long-time exposure to IQ or PhIP. The number of ACF increased over time, 
and at all time-points the numbers of small ACF were predominant. 
It was shown that ACF are induced in rodent colon by colon carcinogens 
such as DMH-2HC1, AOM, IQ, and PhIP and that the incidence of induced 
ACF could be modulated by different dietary components. As no clear 
relation between the outcome of ACF and tumours was found in the studies, 
the results could indicate that ACF and colon tumours represent two parallel 
1 
independent events as a consequence of the cancer initiation, i.e. the ACF 
not being preneoplastic per se. An alternative explanation could be that only 
some of the ACF are precursor lesions for colon tumours and that the time 
point in the colon carcinogenic process, at which the ACF are scored is not 
the ideal to find a true relation between ACF and colon tumours. 
The question whether ACF represent true preneoplastic lesions is still open. 
A better understanding of the early detected lesions in colon carcinogenesis 
in animal models is needed, before the presence of ACF can be interpreted 
as a reliable indicator of a later development of cancer, and the ACF being 
predictive of a human colon cancer potential. 
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SUMMARY IN DANISH (SAMMENDRAG) 
Tyktarmskraft er en af de hyppigste kraftformer hos mennesket, og 
befolkningsundersogelser tyder pa, at hyppigheden af tyktarmskraft i hoj 
grad er knyttet til kostens sammensatning. 
Mange af de forandringer, der ses i tarmslimhinden under udviklingen af 
kraeft hos mennesker, ses ogsH i dyremodeller. Udgifteme og varigheden af 
traditionelle langtidsdyreforsog med endepunktet kraft gor screeningen for 
kostrelaterede modulatorer naesten uendelig. Korttidsundersogelser er derfor 
blevet tiltagende vigtige for denne screeningsproces. 
Naervarende undersogelser blev igangsat med henblik pa at finde en 
intermediser biomarkor, som kunne bruges 1 en korttidstest for screening af 
kostrelaterede modulatorer af tyktarmskraeftudviklingen. 
Den intermediaere biomarkor, der blev valgt til undersogelseme, var en 
histologisk biomarkor, “abenant crypt foci” (ACF). ACF er morfologiske 
forandringer, som p&vises topografisk i Giemsafarvet tyktarm, uden at denne 
er indstobt i paraffin og snittet. 
Forskellige fodertyper med hojt indhold af fedt, kostfiber, stivelse eller 
sukker blev undersogt i ACF-testen i hanrotter initieret med de tyktarms- 
krzftfremkaldende stoffer 1,2dimethylhydrazindihydrochlorid (DMH-2HCl) 
eller azoxymethan (AOM). Kostfiber, stivelse og sukker modulerede de 
DMH-2HCl- eller AOM-inducerede ACF. Det generelle fund var en effekt 
pa det totale antal ACF og pa antallet af sma ACF (l-3 krypter/focus). De 
undersogelser, der fortsatte til .udviklingen af tumorer, viste ingen klar 
sammenhang mellem maengden af ACF og tumorer og de fodertyper, der 
blev undersogt. 
De heterocycliske aminer, 2-amino-3-methyl-imidazo[4,5-Jlquinoline (IQ) og 
2-amino- 1-methyl-6-phenyl-imidazo[4,5-blpyridine (PhIP), inducerede ACF 
hos bade mus og rotter, og hos rotter kunne maengden af ACF moduleres af 
et foder med et hojt indhold af sukker. Effekten sas, ligesom ved DMH- 
2HCl og AOM, pa det totale antal ACF og pa antallet af sma ACF (l-3 
krypter/focus). Selv om IQ og PhIP ikke er kendt for at give tyktarmskraft 
hos mus, blev der pavist ACF hos mus save1 efter kort som lang tids 
udsattelse for IQ eller PhIP. ACF-antallet ogedes med tiden, og pa alle 
m&he tidspunkter var sma ACF de dominerende. 
Forsogene viste, at ACF induceres i gnavertyktarm af stoffer, der giver 
tyktarmskraft, sasom DMH-2HC1, AOM, IQ og PhIP, og at incidensen af 
induce&e ACF kan moduleres af forskellige kostkomponenter. Da der ikke 
blev fundet en klar sammenhaeng mellem maengden af ACF og tumorer, 
kunne resultaterne indicere at ACF og tyktarmskraft repraesenterer to 
parallelle, uafhaengige haendelser som en konsekvens af kraeftinitieringen, 
3 
dvs. ACF er i sig selv ikke forstadier til kraeft. En altemativ forklaring 
kunne vaxe, at det kun er visse ACF, der er forstadier til tyktarmskraft, og 
at det tidspunkt i tyktarmskraeftprocessen ved hvilken ACF scores, ikke er 
det ideelle for at finde en sand sammenhang mellem de preneoplastiske 
ACF og tyktarmstumorer. 
Sporgsmalet, om ACF er sande forstadier til krzft, er stadig uafklaret. Der 
er behov for en bedre indsigt i de tidligt paviste skader i udviklingen af 
tyktarmskraft i dyremodeller, for tilstedevaxelsen af ACF kan tolkes som en 
trovaxdig indikator pa senere udvikling af krzft, og dermed forudsige mulig 
human tyktarmskr~ft. 
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INTRODUCTION 
Epidemiology of colon cancer 
During the past decades, epidemiological studies have indicated that colon 
cancer in humans is induced, in large measure, by substances in our 
environment. Comparative studies of geographical variations in the incidence 
of colon cancer indicate a lo-20 fold difference in incidence between the 
country with the highest and the country with the lowest rate. This variation 
in incidence suggests a large potential for prevention of colon cancer 
(American Cancer Society 1995, Muir et al. 1987). Likewise, in 1981, Doll 
& Peto estimated that 90% of colon cancers in USA could be linked to the 
diet. This estimate has recently been reduced to 70% (range 50-80%) by WC 
Willet (Nelson 1996) because of clear evidence since 1981 that physical 
activity plays an important protective role in colon cancer. 
Colon cancer is the third most frequent cancer in the world in both sexes, 
after cancers of the lung and stomach in males and after those of breast and 
cervix in females (Coleman et al. 1993). 
In 1993, the annual number of newly diagnosed cases of colorectal cancers 
in Denmark was approximately 3300 (Storm et al. 1996). The incidence has 
increased since 1960, and the average annual numbers of deaths in Denmark 
due to cancer of the colon in 1983-1987 was 547 for males and 651 for 
females (Engeland et al. 1995). 
The intestinal mucosa represents one of the largest interfaces between the 
human body and the external environment. It is exposed to a variety of 
ingested carcinogens and to many compounds that may be converted to 
carcinogens by the microflora and the environment within the intestinal 
ecosystem. 
The question whether certain dietary factors could be involved in colon 
cancer has important public health implications, and several hypotheses have 
been put forward concerning the factors responsible for the differences in the 
international incidences. So far the epidemiological data indicate that the 
dietary intake of meat, protein, and fat are consistently positively related to 
risk, while vegetable consumption and probably also foods high in fibre are 
inversely associated with risk (Willett 1989, Potter et al. 1993). 
Because of the inherent weakness and limitations in epidemiological studies, 
laboratory animal models are necessary to support and further explain the 
findings in humans. 
Experimental colon cancer 
Laboratory rodents have been used for long time to predict carcinogenic risk 
in humans. The basis upon which the extrapolation from one species to 
another lies is the similarity among animals and humans at the cellular levels 
(Calabrese 1983). The relevance of rodent studies, with short life spans and 
exposures to high doses of chemical substances, as models for human 
disease processes is sometimes questioned. However, the observation of 
many of the same alterations in human colonic mucosa as in these animal 
models lends some credence to animal models. Although spontaneous 
tumours of the intestine are uncommon in animals, rodents readily develop 
adenomas and carcinomas when exposed to various chemical substances 
(Shamsuddin 1983, Rogers & Nauss 1985a, Goldin 1988). Despite the lack 
of sufficient evidence that these chemicals are human intestinal carcinogens, 
the chemically induced tumours resemble the colon tumours seen in humans 
and thus provide an opportunity to study the effects of diets, chemopre- 
ventive substances and other factors in tumorigenesis (Freeman 1983, Jacobs 
1983, Reddy 1983, Maskens 1983, Ward & Ohshima 1985, Greene et al. 
1987). 
Short-term assay for colon cancer 
The aim of the studies presented was to develop and validate a short-term 
animal model to assess the influence of different dietary components on the 
development of colon cancer. The use of traditional long-term animal studies 
makes this job almost endless because of their duration and cost and due to 
the plethora of dietary components of interest. Therefore, short-term in vivo 
bioassays are recognized as being increasingly vital in the screening process. 
Thus, we looked for an intermediate biomarker which should be recognized 
as a “putative preneoplastic change” that takes place in colonic mucosa prior 
to the development of recognizable malignant disease (colon cancer). Bio- 
markers for colon cancer, if validated, may provide an alternative to the 
traditional testing of dietary modulators using cancer as an endpoint. 
The putative premalignant changes that appear to precede colon cancer, and 
which could be used in a short-term assay for colon cancer, include 
biochemical, molecular, and morphological alterations. Many of these 
changes have been observed in both laboratory animals dosed with colon 
carcinogens and in human colonic mucosa at increased risk for cancer. 
The applicability of short term biomarkers are based upon a number of 
criteria. They should: 
be modulated in frequency by dietary components known to 
influence colon cancer outcome 
have a short “latency time” in terms of weeks 
be able to be assessed in a simple, reliable and quantitative manner 
occur at a frequency high enough to allow for their biological and 
statistical evaluation relevant to cancer 
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Since carcinogenesis in colon is recognized to include multiple genetic 
events (Vogelstein et al. 1988, Kinzler & Vogelstein 1992), the use of single 
biomarkers can be difficult, as they might relate to and be recognizable at 
only one or a few of the many possible stages. 
The intermediate biomarker chosen in the presented studies is a histological 
biomarker, the aberrant crypt foci (ACF) (Bird 1987). ACF are defined as 
morphological lesions identified topographically in intact colons, i.e. not 
embedded in paraffin and sectioned, and thus not defined by their 
histological features (Bird and Pretlow 1992). 
One advantage of this short-term bioassay is that the ACF scored as 
biomarkers subsequently can be isolated by microdissection and further 
analyzed by other methods applicable to fixed tissue. In this way, ACF have 
been identified as having certain characteristics in common with colonic 
tumours in rodents and humans. ACF have been characterized by their 
histological features in terms of grade of dysplasia (McLellan et al. 1991a, 
Roncucci et al. 1991, Pretlow et al. 1992) and proliferative activity 
(McLellan et al. 1991b, Pretlow et al. 1994a, Roncucci et al. 1993). Some 
of the genetic alterations known to be involved in colon carcinogenesis 
(Vogelstein et al. 1988, Kinzler & Vogelstein 1992), have also been detected 
in ACF. Thus K-t-as mutations have been identified in ACF of mice (Zaidi 
et al. 1995), rats (Shivapurkar et al. 1994, Stopera & Bird 1992, Stopera et 
al. 1992b, Tachino et al. 1995), and humans (Pretlow et al. 1993, Smith et 
al. 1994, Jen et al. 1994, Yamashita et al. 1995), and APC mutations have 
been identified in humans (Smith et al. 1994, Jen et al. 1994). Over- 
expression of carcinoembryonic antigen has been detected in human ACF 
(Pretlow et al. 1994b), and in rat colon the expression of c-fos (Stopera et 
al. 1992a) is significantly increased in the ACF. Also the levels of 
proliferating cell nuclear antigen (PCNA), epidermal growth factor receptor 
(EGF-R), transforming growth factor a (TGFa), and omithine decarboxylase 
(ODC) have been found to be increased in ACF isolated from rat colon 
(Berger et al. 1994). The ACF assay is continuously evaluated by the 
extensive research conducted up to now (more than 200 papers on the assay 
since 1987), and the assay is routinely used in the screening program for 
evaluation of potential chemopreventive agents by the National Cancer 
Institute chemoprevention drug development program (Steele at al. 1994). 
The ACF identified in the different studies which are included in the present 
thesis have been characterized further in many parameters (Thorup 1997). 
However, this thesis includes only the morphological features of the ACF in 
the intact unembedded rodent colon. 
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DESCRIPTION OF THE SHORT-TERM ASSAY 
Normal colon crypts 
The normal colon mucosa contains numerous test-tube shaped glands, the 
crypts of Lieberkiihn, of which the single crypt is the unit structure of the 
colon. The crypts are open at the mucosal surface and have a closed base. 
The balance between dividing cells in the deepest third of the crypts and 
migration and exfoliation at the surface maintains the flat-appearing surface 
of the colon (Deschner 1990). The cell population turnover time, defined as 
the time necessary to replace the number of cells present in the entire crypt, 
is reported to be 10 days for rat colon (Bertalanffy 1960) and 3 days for 
mouse colon (Oehlert & Biichner 1961). 
Estimates of the total number of crypts/colon is 405.000 in the rat and 
690.000 in the mouse (Deschner 1990), or 300 to 1000 similar crypts 
covering each square millimetre of the colon surface (Bruce 1990). The 
surface area of the individual crypt does not reveal any change from the 
proximal to the distal part of the rat colon. However, the number of crypts 
decreases markedly along the proximal-to-distal axis due to an increase in 
the epithelial surface between the crypts (Gutschmidt et al. 1983). 
Figure 1. Normal colonic crypt. 
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Colon cancer inducers 
2,2-dimethylhydrazine dihydrochloride (DMH-2HCl) and azoxymethane 
(AOM) . 
DMH-2HCl and AOM have proven to be of great value in experimental 
colon carcinogenesis studies due to their reliable and specific ability to 
produce colon tumours in several rodent species. Accordingly, they are the 
most widely used carcinogens for studying colon carcinogenesis in rodents. 
DMH-2HCl is activated by metabolism via AOM and methyl azoxymethanol 
acetate (MAM) to yield the ultimate carcinogen. Both AOM and MAM are 
more effective than DMH-2HCl on a molar basis. Under physiological 
conditions, MAM is unstable and breaks down to form the strong alkylating 
agent, the methyldiazonium ion. The carcinogenicity of DMH-2HCl and 
AOM, is not definitively known for humans (Jacobs 1983). 
2-amino-3-methyl-imidazo[4,5-flquinoline (IQ) and 2-amino-l-methyl-6 
phenyl-imidazo[4,5-blpyridine (PhIP). 
IQ and PhIP belong to the group of heterocyclic amines which are reaction 
products of proteins that are formed during the heating (cooking, broiling, 
frying or grilling) of protein-containing foods. Both IQ and PhIP are 
mutagenic and carcinogenic in rodents (Eisenbrand & Tang 1993). IQ and 
PhIP are major mutagens present in heated fish and meat to which humans 
are regularly exposed, and epidemiological studies, although not definitive, 
are supportive of an association between dietary heterocyclic amine intake 
and risk of human colorectal cancer (Adamson et al. 1996). 
IQ and PhIP are carcinogenic to the rat colon (Takayama et al. 1984a, Ito 
et al. 1991). Induction of colonic tumours have not been reported with IQ 
or PhIP in mice (Ohgaki et al. 1984a, Esumi et al. 1989, Kristiansen et al. 
1997), but formation of ACF has been seen in mice after both IQ or PhIP 
administration (Tudek et al. 1989), and IQ has been shown to induce nuclear 
aberrations (NA) (i.e. micronuclei, karyorrhexis, and pyknosis (apoptotic 
bodies)) in mice colonic crypts (Bird & Bruce 1984, Dolara et al. 1986). As 
nuclear aberrations are cell-lethal events, the induction of NA suggests that 
IQ, or its active metabolite, is capable of reaching the colonic epithelium 
and exerting nucleotoxic effects. The mechanism behind IQ and PhIP induc- 
tion of colonic lesions (ACF, NA) in mice is not known. Unchanged IQ is 
known to be present in the gut of mice after oral administration, and activa- 
tion of this to a direct-acting genotoxin by the colonic microflora may thus 
lead to DNA damage in the colonic mucosa (Alldrick & Rowland 1988). 
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Carcinogen-induced changes in the crypts 
It is generally believed that colon carcinogenesis, irrespective of animal 
species including man, is a focal and sequential process originating from a 
single crypt. The patterns of cellular alterations seen in colon during cancer 
development are remarkably similar with different chemical carcinogens. 
Probably, a neoplastic transformation of a small fraction of the epithelial 
cells in the colonic crypt is one of the initial steps in carcinogen-induced 
changes. It is very difficult to identify isolated neoplastic transformed cells 
in single crypts. Only when a crypt is partly or entirely populated by 
cytologically atypical cells it can be identified from the normal crypts. The 
atypical cells are generally characterized by their cytoplasmic basophilia, 
loss of goblet cells, a high nuclear-cytoplasmic ratio, prominent nucleoli, 
loss of cell polarity and most importantly an increase in proliferative activity 
(Chang 1984). Such changes have been detected histologically after four to 
nine weekly injections with DMH-2HCl or AOM (Chang 1984, Shamsuddin 
& Trump 1981a, Nakamura & Kino 1982). 
Aberrant colon crypts 
Aberrant crypt foci are distinct morphological lesions readily identifiable 
microscopically from the mucosal surface at a magnification of x 40 in 
unembedded colon tissue stained with methylene blue (Bird 1987). The 
methodology for identifying these lesions is simple. The colons of rats or 
mice treated with a colon carcinogen, are excised, cut open along the 
longitudinal axis and rinsed in 0.9% NaCl solution. The colons are then 
pinned on a cork slab and fixed in 4% neutral buffered formaldehyde. After 
fixation, methylene blue or Giemsa stain is used to visualize the ACF. The 
tissue is placed luminal side up in a petri dish with sufficient phosphate- 
buffered saline to cover the tissue. 
As defined by McLellan & Bird (1988b), these aberrant crypts are larger 
than the normal crypts, have a thickened epithelial layer, frequently have a 
slit-shaped rather that round lumina, and have an increased pericryptal zone 
that separates them from the adjacent normal crypts. The parameters used 
to characterize the ACF are: total number of ACF in a colon and number of 
aberrant crypts per focus (crypt multiplicity). The ACF are often grouped 
into small, medium, large and extra large foci, according to the number of 
crypts per focus. The classification into the individual groups differs among 
investigators. The average number of ACF per colon, total ACF as well as 
the different groupings, are then compared in the treated and control groups. 
The distribution of ACF along the colon sometimes is recorded as well. 
The ACF identified by Bird (1987) with light microscopy of methylene blue- 
stained whole-mount colon appear similar to lesions described earlier with 
scanning electron microscopy (SEM) in rats treated with colon carcinogens 
(Barkla & Tutton 1977, Karlin et al. 1977, Cooke et al. 1984). Likewise, by 
evaluating histological sections from rats treated with DMH-2HC1, Sunter et 
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al. (1978), Carachi et al. (1980) and Kimura et al. (1984), identified lesions 
with the same characteristics as ACF. In grossly normal colonic mucosa 
from patients with sporadic colon cancer similar lesions have been identified 
histologically (Oohara et al. 1980, Shamsuddin et al. 1981b). Compared to 
Bird’s technique where the entire colon of a rodent can be evaluated in less 
than half an hour, the SEM only evaluate approximately 1 cm2 of the colon 
and the analysis of lesions similar to ACF in histological sections would 
require thousands to millions of slides per animal and thus: “identifying the 
early precursor lesions by examining histological sections is analogous to 
looking for a needle in a haystack” (McLellan & Bird 1991). Thus, the ACF 
assay described by Bird (1987) has not identified new putative precursor 
stages in colon cancer, but it has made it possible to examine the entire 
colonic mucosa of a rodent or large areas of human colon in a relatively 
short period of time. 
ACF are induced by colon carcinogens such as DMH-2HCl and AOM in a 
dose-dependent manner in rats and mice (McLellan & Bird 1988a, 1988b, 
Tudek et al. 1989, Bird et al. 1989, McLellan et al. 1991b), appear as early 
as two weeks after a single dose of carcinogen (McLellan & Bird 1988b), 
persist until the development of overt tumours (McLellan et al. 1991a, 
Pretlow et al. 1992a), and are rarely induced by carcinogens targeting other 
organs (McLellan & Bird 1988a, Bird et al. 1989, Tudek et al. 1989). Thus, 
the fortnation of ACF is suggestive of a specific response of the colon to 
colon carcinogens. Two to four weeks after the first carcinogen treatment the 
ACF consist of one to three crypts (Bird 1987, McLellan & Bird 1988b, 
Pretlow et al. 1992a), and with increasing time some of these foci become 
larger (McLellan & Bird 1988b, Bird et al. 1989, Eretlow et al. 1992a). Even 
though the number of ACF is dose dependent, this appears not to be the case 
for the number of crypts per focus (McLellan et al. 1991b). The size of the 
ACF can vary within the same animal. As illustrated by photomicrographs, 
foci of aberrant crypts composed of 2 to >20 crypts from one mouse have 
been presented by McLellan & Bird (1988b), and in a single microscopic 
field (magnification x 20) Bird et al. (1989) showed foci composed of 2 to 
13 crypts in a rat. Nuclear features of dysplasia seem to be present in only 
a minority of ACF (McLellan et al. 1991a). 
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Figure 2. The suggested relation between normal crypts, aberrant crypts, 
ACF, adenomas and adenocarcinomas. l.: Normal crypts, 2: Aberrant crypt 
focus, 3: Adenoma, 4: Adenocarcinomas. 
Bruce and colleagues (1993) have proposed two protocols, an initiation and 
a promotion protocol, for identifying factors likely to be carcinogenic to the 
colon as detected by the ACF assay. 
Control animals 
----P 
I I I 
Test substance ACF scoring 
Figure 3. Protocol for initiators (adapted from Bruce et al. 1993). 
In the protocol for initiators groups of mice or rats are given the test 
substance or the vehicle control/nothing at day 0 and 7 and ACF are scored 
in the colon at day 28. 
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Control diet 
I 
100 days 
I I 
0 7 
Test diet 
ROM treatment - I 1 
ACF scoring 
Figure 4. Protocol for promoters (adapted from Bruce et al. 1993). 
In the promoter protocol the animals are initiated with AOM once a week 
for two weeks, and then treated with test diet or controi diet. After 100 days 
the colons are scored for ACF. As seen in the ACF literature this protocol 
can be used to test possible inhibitors as well, and thus a more appropriate 
name would have been “Protocol for modulators”. 
Even though the protocols outlined by Bruce et al. (1993) have been used 
by several investigators, still it is very difficult to compare the results 
obtained by different investigators as a standardized protocol not yet has 
been adopted. 
Other colon carcinogens than DMH-2HCi and AOM have been shown to 
induce ACF in rodent colon (APPENDIX, Table 1) and the lesions are 
clearly modulated by dietary factors, certain drugs, and miscellaneous other 
agents (APPENDIX, Table 2-4). Table 2, 3, and 4 give some examples of 
the modulating effect on the development of ACF of a series of compounds. 
The protocols used in the different experiments included in these tables are 
not comparable as several parameters which could influence the test results 
vary between the experiments, i.a. animal species and strain, colon 
carcinogen, dose and dosing regimen, the control diet used, duration of 
feeding with test diet, and feeding test diet in relation to time for carcinogen 
treatment. So, Tables l-4 are meant only to give some examples of the 
different substances used for evaluating the ACF assay during the decade 
since the assay was described for the first time (Bird 1987). 
That ACF are associated with colon carcinogenesis is supported by human 
data. Jncreased frequencies of ACF have been detected in normally 
appearing human colonic mucosa from patients with sporadic colon cancer 
and in patients with hereditary conditions that predispose to colon cancer, 
such as Gardner’s syndrome (Pretlow et al. 1991) and familial adenomatous 
polyposis (FAP) (Roncucci et al. 1991). Many of the features seen in rodent 
ACF after microdissection and application of specific techniques have been 
detected in human ACF, i.e. dysplasia (Roncucci et al. 1991), proliferative 
activity (Roncucci et al. 1993), K-t-as mutations (Pretlow et al. 1993, Smith 
et al. 1994, Jen et al. 1994, Yamashita et al. 1995), APC mutations (Smith 
et al. 1994, Jen et al. 1994) and over-expression of carcinoembryonic antigen 
(Pretlow et al. 1994b). Thus, the similarity of ACF in rodents and humans 
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lend support to the use of the rodent ACF assay as model for human colon 
cancer. 
Most recently Moen et al. (1996) have emphasized the importance of taking 
genetic factors into account when evaluating the predictive value of the ACF 
assay for colon carcinogenesis. It has been known for long time that 
susceptibility to colon cancer is strongly strain dependent in mice, and partly 
strain dependent in rats, in which also males are more susceptible than 
females (Rogers & Nauss 1985a). CFl and SWR mice are the most sensitive 
mouse strains to DMH-2HC1, reacting with almost 100% incidence of colon 
cancer (Thurnherr et al. 1973, Diwan et al. 1977), the C57BL/6J strain is 
moderately resistant to DMH-2HC1, producing a 43-48% tumour incidence 
(Diwan et al. 1977, Diwan & Blackman 1980), and AKR and DBA mice are 
extremely resistant to the carcinogen (Evans ei al. 1974, Diwan et al. 1977). 
In rats Brown-Norway and Wistar-Furth are somewhat iess susceptible than 
Fischer or Sprague-Dawley rats, which appear to be about equally suscepti- 
ble (Rogers & Nauss 1985b). 
This strain dependency has also been reported in the ACF assay. In mice 
strain differences have been found between CF, and C57BL/6J (Bird 1987, 
McLellan & Bird 1988a, 1988b, Stamp et al. 1993), between C57BL/6J and 
BALB/Cj mice (Kendall et al. 1992), between AKR/J, DBA/2J, SWR/J and 
P/J (Rosenberg & Liu 1995), and between BALB/Chhea, STSIA and 
CcS/Dem (9 strains) mice (Moen et al. 1996). Even though most of these 
studies suggested a relation between susceptibility to ACF and colon 
turnouts, only the study by Moen et al. (1996) evaluated ACF and tumour 
outcome in the same animals under the same conditions. They found no 
agreement in three of the strains tested. Accordingly, the strain BALB/cHeA 
had high numbers of ACF and low numbers of tumours, indication that ACF 
not always progress to tumours; and the strains CcS-5 and STS/A had low 
numbers of ACF and high numbers of tumours. The authors suggest several 
mechanisms to this absence of an agreement between susceptibility to ACF 
and colon tumours and conclude that at least some genes that control the 
susceptibility to ACF are different from those involved in the susceptibility 
to colon tumours. 
Likewise, strain differences in incidence of ACF have been detected between 
Fischer 344 and Lewis rats (Steffensen et al. 1995). The sex difference in 
colon carcinogenesis in rats has been demonstrated in ACF formation as 
well, by feeding Fischer 344 rats the heterocyclic amine PhIP. PhIP induces 
colon tumours in male, but not in female rats, and even though ACF were 
induced in both sexes, males had significantly more total ACF (x 3.5) than 
females (Ochiai et al. 1996). 
The role of genetic susceptibility to colon carcinogenesis is also demon- 
strated by use of different intestinal mouse models. Mice with defects in the 
adenomatous polyposis coli (APC) gene are among the more promising in 
research on cancer of the digestive tract. Several mouse lineages heterozy- 
gous for specific mutations at the endogenous Apt gene have now been 
developed and characterized with respect to their intestinal tumour 
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multiplicity (Fodde et al. 1996). The mutation in the murine Apt gene render 
mice like Min (multiple intestinal neoplasia) (Moser et al. 1989), Apti716 
(Oshima et al. 1995a,), and Apc1638N (Fodde et al. 1994, 1996), highly 
susceptible to spontaneous intestinal adenoma formation. ACF have been 
found to occur spontaneously in Apc1638N mice and at increased frequency 
after PhIP treatment (Sorensen et al. 1997). Increased number of ACF after 
treatment with PhIP has also been detected in C57BL/6J-Min/+ mice 
(Steffensen et al. 1996). Spontaneous occurrence of ACF was not seen in 
these C57BL/6J-Min/+ mice, but crypts with morphological features, 
different from what is found with AOM were detected. However, 
histopathological examination of these crypts showed dysplastic changes, 
similar to AOM-induced ACF (Paulsen et al. 1996a). In other studies 
spontaneous ACF were extremely rare in C57BL/6JMin/+ mice (Jacoby et 
al. 1996, Pierre et al. 1997), and in ongoing studies at the Institute of Food 
Safety and Toxicology with C57BL/6JMin/+ mice spontaneous occurrence 
of ACF has not been detected. App716 mice have been reported not to 
develop ACF spontaneously (Oshima et ai. 1995b, 1997). 
Additionally, the importance of genotype in the susceptibility for ACF 
formation has been proven by crossing male Min mice (Apt”‘) with germ 
line DNA mitchmatch repair (MMR) gene (M&)-deficient female mice 
(Msh2”~), a mutation believed to be important during the rapid progression 
of the adenoma-to-carcinoma sequence in patients with hereditary nonpoly- 
posis colorectal cancer. Spontaneous ACF were quite rare in Apt+‘-/M&2+‘- 
and Ap~~‘-lMsh2+~+ mice but were abundant in Apt”-/Msh2”‘ (Reitmair et al. 
1996a). Transgenic homozygous Msh2”- mice also develop ACF spontane- 
ously (Reitmair et al. 1996b). Tissues and cells having high levels of 
alkyltransferases are more resistant to mutagenic and carcinogenic effects of 
alkylating agents (Zaidi et al. 1995). When transgenic mice over-expressing 
MGMT, which codes for the human protein 06-alkylguanine-DNA alkyltrans- 
ferase, in their colon, and hence having increased alkyltransferase activity 
in the colon, were treated with AOM fewer ACF were developed compared 
with non-transgenic mice (Zaidi et al. 1995). 
Most recently Paulsen et al. (1996b) and Feng et al. (1996) have found that 
the acetylator genotype in Syrian hamsters is a determinant of the develop- 
ment of ACF induced by the aromatic amine colon carcinogen 3,2’-di- 
methyl-4-aminobiphenyl (DMAB). N-acetylation capacity is linked to 
chemical-induced toxicity and human epidemiological studies are indicative 
of an association between colorectal cancer and rapid acetylator phenotype. 
After treatment with DMAB male Syrian hamsters of homozygous rapid 
acetylator genotype developed substantially more ACF than those of 
homozygous slow acetylator genotype. 
In conclusion, the scientific literature reflects increasing evidence that the 
occurrence of ACF is linked to the induction of colon cancer both in animal 
models and in man. However, the experimental induction of ACF is 
influenced by several factors like e.g. species and strain of the laboratory 
animal, the diet, and the dose regimen. 
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OWN INVESTIGATIONS 
In the first experiment archived colon tissue from a previous experiment 
(Thor-up et al. 1992) using a classical rat model for carcinoma of the colon, 
was evaluated for the formation of ACF-(Paper I). The rats had been treated 
with DMH-2HC1, and the modulating effect of a dietary fibre on colon 
cancer was investigated. 
Due to the duration and cost of the classical rat colon cancer model the ACF 
assay was chosen as a possible assay in future studies. In the next studies 
the classical colon carcinogens, DMH-2HCl and AOM were used as inducers 
in rats and different diets were tested for their modulating effect on the 
development of ACF in colon (Paper II and III). 
Most recently the heterocyclic amines PhIP and IQ, which are believed to 
be involved in the initiation of human colon cancer (Paper IV, V and VI) 
were used instead of the model colon carcinogens DMH-2HCl and AOM. 
MATERIALS AND METHODS 
A. Detection of ACF in colons from rats with carcinogen-induced 
tumours (Paper I). 
Archived colon tissue from male Wistar rats in a one year study investiga- 
ting the effect of a dietary fibre on experimentally induced colon cancer, was 
examined for the formation of ACF. In the one year study DMH-2HCl was 
used as initiator in a dosage of 20 mg/kg body weight, given by gavage once 
a week for 10 weeks. The dietary fibre tested was a beet fibre (Fibeta), and 
the two levels of Fibeta, added to the semisynthetic diet, corresponded to 
0.7% and 14% dietary fibre in the rat diet. The study was designed to 
investigate the modulating effect of Fibeta during the periods of preinitiation, 
initiation, promotion, and progression. Groups of 30 rats, 60 controls, were 
initiated by DMH-2HC1, and throughout the study the rats were offered diets 
with different amounts of fibre on different time of the experimental period. 
As parts of the colon tissue from the rats in this study had already been 
processed for tumour characterization, only a minor part of the residual 
colon was selected for the ACF examination. The middle 1.5 cm of the 
major flexure (here defined as the colon segment situated from 7 cm to 12 
cm from the junction between caecum and colon) was chosen. The ACF 
were grouped into small (l-3 crypts/focus), medium (4-6 crypts/focus), or 
large (27 crypts/focus) foci. 
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Experimental conditions, Paper I 
Group n 
% Fibeta in Diet 
DMH-HCI, 
8 Wks Preinit 10 Wks Init 30 Wks Postinit mg/kg bw/wk 
I 60 
II 30 
III 30 
IV 30 
V 30 
VI 30 
VII 30 
VIII 30 
IX 30 
1 
1 
20 
20 
20 
20 
1 
1 
1 
1 
1 
1 
20 
20 
20 
20 
1 
20 
1 
1 
1 
1 
20 
20 
1 
20 
20 
0 
20 
20 
20 
20 
0 
20 
20 
20 
B. Modulating effect of different diets on the development of 
ACF and colon tumours in rats induced by DMH-2HCI or 
AOM (Paper II and III). 
Two protocols were used to evaluate. the modulating effect of different diets 
on carcinogen induced ACF. 
The first protocol used oral administration of DMH-2HCI, 20 mg/kg body 
weight, once a week for 10 or 20 weeks to male Wistar rats. Three semisyn- 
thetic diets were tested: 1) a diet rich in sucrose and dextrin; 60% of the 
diet, 2) a high-fat-low-fibre diet (20% lard, 4% cellulose), and 3) a high-fat- 
high-fibre (20% lard, 20% beet fibre, 4% cellulose). The diets were fed 
during and after the DMH-2HCl dosing. ACF in the entire colon were 
recorded after 10 weeks (10 rats/ group), 20 weeks (8 rats/group), and 3 1 
weeks (10 or 20 rats/group). The ACF were grouped into small (l-3 
crypts/focus), medium (4-6 crypts/focus), large (7-9 crypts/focus), or extra 
large (2 10 crypts/focus) foci. The predictive value of the ACF was further 
evaluated by investigating whether there was a correlation with the incidence 
of colonic turnouts after 3 1 weeks (10 or 20 rats/group). 
Experimental conditions, Paper Wb 
Group 10 wks 20 wks 
DMH-2HCI Dh4H-2HC1 
20 Wks DMH-2HCl+ 
11 Wks Post treatment 
Control 10 8 10 
Diet 1 10 8 10 
Diet 2 10 8 20 
Diet 3 10 8 20 
a: 
b: 
Dimethylhydrazine &hydrochloride (DMH-2HCl), 20 mg/kg body wt/wk. 
Values are expressed as no. of rats. 
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The second protocol used subcutaneous injections of AOM, 15 mg/kg body 
weight, once a week for two weeks to male rats. At the end of the dosing 
period the rats (14 rats/group) were given different test diets for 16 weeks. 
The 67% carbohydrate mix in the semisynthetic control diet was composed 
of 45% cornstarch, 45% potato starch, 5% sucrose, and 5% dextrin. In the 
three test diets the carbohydrate mix was replaced by 67% sucrose, 67% 
potato starch, and 67% cornstarch, respectively. The two starches tested were 
characterized by their high content of resistant starch (which physiologically 
may act as a dietary fibre), 55% in potato starch, or low content of resistant 
starch, 7% in cornstarch. At the end of the study all rat colons were 
evaluated for formation of ACF. The ACF were grouped into small (l-3 
crypts/focus), medium (4-6 crypts/focus), large (7-9 crypts/focus), or extra 
large (2 10 crypts/focus) foci. 
Experimental conditions, Paper III 
Group I II III IV 
Carbohydrate mix L % 67 0 0 0 
Sucrose, % 0 67 0 0 
Potato starch, % 0 0 67 0 
Cornstarch, % 0 0 0 67 
a: Carbohydrate mix: 45% cornstarch, 45% potato starch, 5% sucrose, 5% dextrin. 
C. The heterocyclic amines 2-amino-3-methyLimidazo[4,5- 
flquinoline (IQ) and 2-amino-1-methyl-6-phenyLimidazo[4,5- 
blpyridine (PhIP) in the ACF assay (Paper IV, V and VI). 
The food-related carcinogens selected for the next ACF studies were the two 
heterocyclic amines, 2-amino-3-methyl-imidazo[4,5-flquinoline (IQ) and 2- 
amino-1-methyl-6-phenyl-imidazo[4,5-blpyridine (PhIP). 
In the first study (Paper IV) IQ and PhIP were tested in the ACF-assay in 
female C57BL/6J mice for 4 (4 mice/group) or 10 weeks (10 mice/group) 
using a feeding regimen with continuous low doses of IQ and PhIP to 
simulate human exposure. To evaluate the potency of IQ or PhIP as initia- 
tors in the ACF-assay, DMH-2HCl and AOM were tested as well. 
Throughout the study groups of mice were offered a pellet diet, Altromin 
1314, supplemented with 0.03% (wt/wt) IQ or 0.03% (wt/wt) PhIP. 
Additional groups were dosed intraperitoneally (10 ml/kg body weight) with 
AOM (5 mg/kg body weight) or DMH-2HCl (20 mg/kg body weight), 
respectively, once a week for two weeks. Four and ten weeks after initiation 
of the study mice were sacrificed and their colons evaluated for ACF 
formation. 
Based on the results from the mouse study it was decided to use rats for the 
next study (Paper V). IQ was chosen as initiator and groups of male Fischer 
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rats (lO/group) were given a semisynthetic pellet diet without or with 0.03% 
(wt/wt) IQ thr oughout the 10 weeks study. Two test diets were used: 1) a 
diet with a carbohydrate mix composed of 90% starches and 10% 
dextrin/sucrose and 2) a diet with 10% starches and 90% dextrin/sucrose. 
After 10 weeks, colons were examined for the formation of ACF. 
The predict&e value of the ACF was further validated by quantitating 
colonic tumours (data still under evaluation). 
In the mouse study with IQ and PhIP (Paper IV), both agents were able to 
induce ACF in the colon of mice after respectively 4 and 10 weeks of 
exposure. In order to investigate the possible role of PhIP- and IQ-induced 
ACF in the development of colon cancer in mice, the third study on food 
mutagens as initiators of ACF was initiated (Paper VI). Colons from mice 
in other IQ- and PhlP-studies of much longer duration than that of paper IV 
were analyzed for ACF and the number of ACF at different time periods 
were evaluated. Wild type female mice, C57BL/6ByA and C57BL/6J, were 
used. The PhIP study included fifteen C57BL/6ByA mice given 0.03% 
(wt/wt) PhIP in the diet for 31 weeks, and with duration periods up to 78 
weeks before ACF quantitation (SGrensen et al. 1996, Kristiansen et al. 
1997). The IQ study included eighteen C57BL/6ByA mice given 0.03% 
(wt/wt) IQ in the diet for 24 weeks, and a study period of 40 weeks 
(Sgrensen et al. 1996). The main purpose of these two studies was not to 
study ACF formation, and hence the studies were not designed as regular 
ACF-studies. However, due to the long duration of the studies, an investi- 
gation of the colons for ACF formation could add information about the fate 
of the early (4 and 10 weeks) recognized ACF. 
Experimental conditions, Paper VI 
Mouse strain Treatment Treatment period/Duration 
C57BL/6ByA 
C57BL/6ByA 
C57BL/6J 
F 0.03% PNP, diet 31Wkd31 or up to 78 Wks 
+ 0.03% IQ, diet 24 Wksl40 Wks 
+ 0.03% PhlP or IQ, diet 4andlOWks 
RESULTS 
A. Detection of ACF in colons from rats with carcinogen-induced 
tumours (Paper I). 
The results presented in this paper showed, in general, a statistically 
significant inverse relation between duration of intake of a high-fibre diet 
and number of rats with ACF, total number of ACF/rat and number of small 
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(l-3 crypt/focus) ACF/rat. The ACF results did not correlate with the tumour 
results, as no effect of the dietary fibre on colon tumour incidence in any 
stages of the carcinogenic process was seen (Thor-up et al. 1992). Besides, 
no relation between high numbers of ACF and presence of colon tumours 
were seen in the individual rats. 
EL Modulating effect of different diets on the development of 
ACF and colon tumours in rats induced by DMH-2HCl or 
AOM (Paper II and III). 
The results in paper II showed that different dietary compositions were able 
to influence the development of ACF. Rats fed a diet high in refined 
carbohydrates had a statistically significant higher total number of ACF, and 
a higher number of small and medium ACF than the controls. The high-fat 
diet had no effect on the development of ACF, but adding dietary fibre to 
the high-fat diet resulted in a statistically significant reduction in the total 
number of ACF and the number of small and medium ACF. The effect of 
diets on development of ACF was not reflected in the tumour outcome 
(benign or malignant), as no statistically significant differences were seen 
between the groups. However, the rats on diet high in refined carbohydrate 
had the highest tumour incidence and the individual tumours were larger, 
reddish and cauliflower-like. Based on individual rat findings no relation 
between high numbers of ACF and presence of colon tumours was seen. 
Study III revealed a marked inhibitory effect of potato starch on the 
development of ACF in the rats. Animals fed potato starch diet had a 
statistically significant lower number of total ACF as well as ACF in all 
categories but small. No effect of sucrose or cornstarch was seen. The 
animals receiving the potato starch diet showed a statistically significant 
reduced body weight gain after 5 weeks on experimental diet and a 
concomitant decrease in food consumption. 
C. The heterocyclic amines 2-amino-3-methylknidazo[4,5- 
flquinoline (IQ) and 2-amino-1-methyl-6-phenylknidazo[4,5- 
blpyridine (PhIP) in the ACF assay (Paper IV, V, and VI). 
In the study where mice were continuously fed low doses (0.03%) of IQ or 
PhIP (Paper IV), ACF were detected after 4 weeks. No ACF were seen in 
the AOM and DMH-2HCl dosed mice at that time. After 10 weeks ACF 
were found in all dosed groups. IQ-dosed mice had a statistically significant 
higher number of small and total ACF than the other groups after 4 as well 
as 10 weeks. Compared to the ACF induced by IQ or PhIP, AOM and 
DMH-2HCl induced a higher percentage of medium and large size ACF. 
A comparable feeding regimen of continuous low IQ-doses (0.03%) 
throughout a study period of 10 weeks significantly increased the number of 
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small ACF as well as the total number of ACF in the-colon of male F344 
rats (Paper V). Additionally, the study showed that the incidence of IQ- 
induced ACF could be influenced by a diet high in refined carbohydrate. 
The total number and the number of small ACF were statistically significant- 
ly higher in rats given the high carbohydrate diet compared to rats fed the 
control diet. Whether the effect of the high carbohydrate diet on ACF 
induction is reflected in colon tumour incidence will be seen at termination 
of the study (data still under evaluation). 
The results in paper VI, where colons from mice from IQ- and PhIP-feeding 
studies of different duration were investigated, showed that the number of 
ACF increased statistically significantly over time, and that the small ACF 
were predominant at all time-points. IQ induced ACF at a much higher 
number than PhIP, but no colon tumours were found in either IQ or PhIP 
dosed mice. 
DISCUSSION 
The studies of the present thesis have shown that ACF are induced in rodent 
colon by colon carcinogens such as DMH-2HC1, AOM, IQ, and PhIP and 
that the incidence of induced ACF can be modulated by different dietary 
components. 
The best way to evaluate the tumour predictive value of the assay is to 
assess the ACF and tumour incidence in the same animals under the same 
conditions. 
Both of the studies proceeding to tumour formation (Paper I and II) did not 
show a clear relation between the outcome of ACF and tumours with any of 
the dietary components tested. Neither a clear relation, based on individual 
rat findings, between high numbers of ACF and presence of colon tumours 
was seen. A third study is still under evaluation. 
In general, the most consistent finding in all experiments was that if a 
modulating effect of a tested diet was found, the effect was exerted on the 
total number of ACF and the number of small (l-3 crypt/focus) ACF. In one 
example using the protocol proposed by Bruce et al. (1993) (AOM injection, 
once a week for 2 weeks) a modulating effect of a high potato starch diet 
was seen in all categories of ACF but small (Paper III). 
Accumulating evidence now supports the hypothesis that total numbers of 
ACF and numbers of small ACF are not significantly related to tumour 
incidence. Pretlow et al. (1992a), Magnuson et al. (1993), Zhang et al. 
(1992), Bird (1995b), Shivapurkar et al. (1994, 1996) all found that the 
number of ACF with multiple crypts rather than the total number of ACF 
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correlated with tumour incidence. In the light of this hypothesis our results 
could be interpreted as if all the tested diets except one had little effect on 
the endpoint colon cancer. However, either the choice of different protocols 
could explain the difficulties in interpreting the results, or the ACF and 
colon tumours could represent two parallel independent events as a 
consequence.of the cancer induction, i.e. the ACF not being preneoplastic 
per se. 
Study design 
Compared to the protocol for ACF studies proposed by Bruce et al. (1993) 
we used multiple DMH-2HCl doses (20 mg/kg body weight for 10 or 20 
weeks) in paper I and II. We decided to use repeated doses of carcinogen 
due to difficulties in obtaining colon tumour incidences high enough to 
enable the measuring of an inhibitory effect of a test compound. Thus, in the 
experiment (Thor-up et al. 1992) that formed the basis for paper I, using 
DMH-2HC1, 20 mg/kg body weight once a week for 10 weeks, only 
approximately 30% of the rats developed colon tumours. With the aim of 
obtaining a higher incidence of cclon tumours a study (unpublished) was 
initiated using doses of 40.5 mg/kg body weight or 81 mg/kg body weight 
DMH-2HC1, once a week for 10 weeks. This study showed that even though 
it was possible to induce colon tumours at an incidence of about 80%, 
serious toxic effects to vital organs such as liver and kidney as well as 
tumours of the kidneys and Zymbal gland and deaths were induced. A 
relatively low incidence of colon tumours as obtained in our studies with 
Wistar rats by a dosing regimen normally capable of inducing a substantially 
higher amount of colon tumours (Shamsuddin 1983), has also been observed 
in studies with Wistar rats conducted at the TNO-CIVO Toxicology and 
Nutrition Institute Zeist, The Netherlands (C.F. I&per, personal communica- 
tion). 
Our use of multiple doses of the carcinogen, has been questioned by Bird 
(1995a). Yet little knowledge is available about the effect of one vs. multiple 
injections of a colon carcinogen on the induction and growth features of 
ACF. By injecting Sprague Dawley rats subcutaneously with one, two or 
four injections of AOM (10 mg/kg/week) followed by sacrifice at week 6, 
14 and 28, Bird (1995a) found that: “the initial response to repeated 
exposure to AOM was characterized by a lag period during which ACF 
appeared indolent before the growth stimulating effect of AOM became 
evident”. Therefore it was suggested that enumeration of the number and 
growth characteristics of ACF determined immediately after repeated 
treatment with a colon carcinogen may not predict tumour incidence. 
How critical the carcinogen dose is in ACF induction was recently 
demonstrated by Bird & Lafave (1995). ACF induced by a single dose of 5 
mg/kg AOM and scored after 8 weeks consisted of crypts that were larger 
in size and responded differently to growth modulation by diet than those 
induced by 20 mg/kg AOM. The authors proposed that the marked 
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cytotoxicity known to be induced by the high dose of AOM, and followed 
by hypo- then hyperproliferative responses, results in more stable preneo- 
plastic lesions as a result of their clonal selection and expansion. A low dose 
of AOM would then be expected to have less effect (Bird & Lafave 1995). 
Our evaluation of only a small segment of the colon (Paper I) has been 
criticized (Bird 19952) for not having been validated, and only used by one 
other research group (Hardman et al. 1991). Nevertheless similar effect of 
the same dietary fibre, i.e. no association between ACF and tumour inci- 
dence, was found in the next study evaluating the entire colon (Paper II). 
Even though the reservation expressed by Bird (1995a) seems relevant, it is 
possible to find other examples in the literature on the ACF assay where the 
entire colon has not been evaluated(Duranton et al. 1997, McLellan et al. 
1991a, Pereira et al. 1996a, Zarkovic et al. 1993, Young et al. 1996). In 
addition, one must bear in mind, that all the human data, which are also 
used in support of the hypothesis that ACF are putative precursor lesions to 
colon cancer, have been obtained from only minor segments of the human 
colon. 
Rodent species and strain/stock 
Even though Wistar rats are reported to be less susceptible to colon cancer 
than Fischer rats (Rogers & Nauss 1985b), no difference with respect to 
tumour incidence was found in our study (unpublished) comparing Sprague- 
Dawley, Fischer 344, and Wistar male rats, treated with DMH-2HC1, 20 
mgjkg body weight/week for 10 weeks. Therefore, Wistar rats were chosen 
in most of the studies presented here, as this strain has been used in 
toxicologic research at the Institute for more than 20 years, and thus a 
considerable amount of experience, biological as well as pathological, has 
accumulated. 
Even though the ACF literature comprises many studies using mice, the use 
of mice has been questioned. In a study by Carter et al. (1994) using DMH- 
2HCl-treated mice the authors proposed that ACF have little if any 
malignant potential in the mouse. Likewise, Steele & Kelloff (1993) testing 
42 chemopreventive agents found that all of the false positive data (positive 
crypt/negative tumour) were derived from mouse tumour studies and the 
authors indicated that some species differences may exist. Additionally, no 
obvious relationship between susceptibility to ACF and susceptibility to 
colon adenomas has been found in certain mouse strains, suggesting that 
some genes that control the susceptibility to ACF are different from the 
genes that are involved in the susceptibility to colon adenomas (Moen et al. 
1996). 
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Dietary fibre - 
A significant effect of a dietary fibre (a beet fibre) on the development of 
ACF without a concomitant effect on tumour incidence was seen in both 
tumour studies (Paper I and II). In both studies a statistically significant 
reduction was seen in the total number of ACF and the number of small 
ACF. If the hypothesis that a reduction in the total number of ACF and the 
number of small ACF is not predictive for a reduction in tumour incidence 
is true, then the study did not show that the dietary fibre tested had a protec- 
tive effect on the induction of colon cancer in rats with the protocol used in 
the two studies. 
A reduction in ACF after feeding dietary fibre to carcinogen treated rats has 
been shown with flaxseed (total no. of ACF) (Serraino & Thompson 1992, 
Jenab & Thompson 1996), wheat bran (total no. of ACF) (Alabaster et al. 
1995), (total no. and A-4 crypts) (Ferguson & Harris 1996), (total no. of 
ACF) (Ishizuka & Kasai 1996) and low risk diets (high fibre and calcium, 
low fat) (total no. and medium size ACF) (Hardman et al. 1991). Bearing 
the above hypothesis in mind, the stated protective effect on development of 
colon cancer of the different fibres in these experiments could be questioned. 
The data in paper II did not support a modulating effect of a high-fat diet 
on the development of ACF shown in other studies (Shivapurkar et al. 1992, 
McLellan & Bird 1988b, Bird & Lafave 1995, Bird et al. 1996, Morotomi 
et al. 1997). Neither did the high-fat diet have any effect on tumour 
incidence. 
Refined carbohydrates 
The enhancing effect of diets high in refined sugars on ACF development 
was demonstrated in two of the three studies with high sucrose diets. The 
modulating effect on ACF by refined carbohydrates seemingly was inducer 
dependent. 
An enhancing effect was seen after ACF-induction with DMH-2HCl (20 
mg/kg weekly). The total number of ACF increased 2.7-fold after 10 weeks 
feeding compared to controls. The highest increase was seen in the number 
of small ACF, but the number of medium, large and extra-large ACF were 
increased as well (Paper II). 
Rats given continuous low doses of IQ (0.03%) for 10 weeks together with 
a diet rich in refined carbohydrates had a statistically significantly higher 
number of small and total number of ACF compared to IQ-dosed animals 
given standard diet. The increase in total number was approximately two 
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fold. The highly refined carbohydrate diet induced a lower, but statistically 
not significant number of medium size ACF (Paper V). 
When AOM was used as initiator (15 mg/kg weekly for two weeks) no 
effect was seen on the total number of ACF after 10 weeks feeding on a 
high carbohydrate diet. The number of medium, large and extra-large ACF 
were all reduced compared to the controls and only the number of small 
ACF was increased (1.4-fold) (Paper III). Inducer dependency is further 
discussed for other compounds on page 3 1. 
The enhancing effect of diets high in refined carbohydrates on development 
of ACF has been reported by others (46 % sucrose in the diet, increase in 
ACF with 3-6 AC/foci, Caderni et al. 1991); (10 g/kg body weight as one 
bolus, increase in total no. of ACF, Stamp et al. 1993), and epidemiological 
studies have indicated that refined sugar may be a risk factor in human colo- 
rectal cancer (Bristol et al. 1985, Macquart-Moulin et al. 1987, Tuyns et al. 
1987, 1988, La Vecchia et al. 1993). 
Starch 
Diets containing relatively large amounts of resistant starch, seemed to have 
a protective role on the development of ACF (Paper II and III). 
In paper II the carbohydrate pool in the control diet mainly consisted of 
starches (45% cornstarch, 45% potato starch, 5% sucrose, and 5% dextrin), 
and compared with the high sucrose diet group (45% sucrose, 45% dextrin, 
5% potato starch, and 5% cornstarch) fewer ACF were seen in the control 
group. Both potato starch and cornstarch contain resistant starch (55% and 
7%, respectively), which physiologically may act as a dietary fibre, and 
hence explain the difference in ACF between the two groups. 
As resistant starch may be of importance as a protective factor also in 
human cola-rectal cancer (Cummings & Bingham 1987, Bingham 1990, 
Cassidy et al. 1994), diets with different amounts of resistant starch were 
tested in the next study (Paper UI). Potato starch (67% of the diet = 37% 
resistant starch) had a marked effect on ACF development, as a statistically 
significant lower number in all categories of ACF but small was seen 
compared to controls (30 % potato starch = 17% resistant starch in the diet). 
An effect of the lower daily caloric intake observed in this group can not be 
excluded. Lasko & Bird (1994) have shown that caloric restriction reduces 
the total number of AOM-induced ACF and colonic adenomas in rats. The 
inhibitory effect of caloric restriction on tumour development has been 
known for decades. 
The opposite effect, i.e. an enhancing effect of potato starch on carcinogen 
induced ACF (95% being of small size) has recently been reported in 
Sprague Dawley rats, an effect which was also reflected in the tumour inci- 
dence (Young et al. 1996). No effect on body weight was seen in the potato 
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starch group in this study. In the potato starch diet 20% of the carbohydrate 
mix (72% of the diet) was raw potato starch = 14.4% potato starch in the 
test diet. The resistant starch content in the diet was reported as 20 % wt/wt 
of total starch based on resistant starch analyses of the pellets = 14.4% 
resistant starch in the diet. The animals in the Young et al. (1996) study 
were fed this diet for 31 weeks, and were injected 10 times subcutaneously 
with DMH-2HC1, 20 mg/kg body weight/week from week 2 to 11. The use 
of 10 weeks carcinogen treatment, simultaneously with feeding the test diet 
compared to the two weeks treatment prior to the test diet feeding in paper 
III in combination with a potato starch content in the diet approximately 2.5 
times lower than that in paper III, and finally a longer experimental period 
than ours (31 vs. 16 weeks) all are factors which could explain the different 
results obtained. In other rat studies, resistant starch added to the diet has 
been found to decrease the number of ACF (Maziere et al. 1996 (primarily 
small size), Perrin et al. 1996). 
The diet which was high in cornstarch (67% of the diet = 5% resistant 
starch) had no inhibitory effect on the formation of ACF. The amount of 
resistant starch in the cornstarch diet was somewhat lower than in the 
control diet, 5% vs. 17%, which might explain the higher, although 
statistically not significant, number of total and small ACF found in this 
group compared to controls. Cornstarch diets (46 % of the diet) have earlier 
been described as having a reducing effect on the size of the DMH-2HCl- 
induced ACF (Cademi et al. 1991). 
Colon cancer inducers of dietary relevance 
The carcinogenicity of the most widely used carcinogens for studying colon 
carcinogenesis in rodents, DMH-2HCl and AOM, is not definitively known 
for humans. For the identification of the component of the human diets that 
might be responsible for the causes of colorectal cancer the use of food- 
related carcinogens in the ACF assay might in a better way reflect the diet- 
related carcinogenesis in humans. 
The food-related carcinogens selected for the ACF studies were the two 
heterocyclic amines, 2-amino-3-methyl-imidazo[4,5-flquinoline (IQ) and 2- 
amino- 1-methyl-6-phenyl-imidazo[4,5-blpyridine (PhIP). 
Mouse studies 
In the mouse study (Paper IV), feeding continuous low doses (0.03%) of IQ 
or PhIP, ACF (almost solely small ACF) were detected after both 4 and 10 
weeks. Seemingly, IQ is a much more potent ACF inducer in the mouse 
colon than both PhIP, DMH-2HCl and AOM with respect to total number 
of ACF and small ACF. The well known mouse colon carcinogens AOM 
and DMEI-2HCl induced a substantially higher percentage of medium or 
large size ACF than PhIP or IQ supporting the theory that ACF with a 
higher crypt multiplicity is more predictive concerning the development of 
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colon cancer (Pretlow et al. 1992a, Magnuson et al. 1993, Zhang et al. 1992, 
Bird 1995b, Shivapurkar et al. 1994, 1996). 
IQ and PhIP have earlier been reported to induce ACF in female CD1 mice 
in a three week study by Tudek et al. (1989) in which a few ACF were 
observed after administration of two doses of IQ (total 400 mg/kg body 
weight) and PhIP (total 150 mg/kg body weight). As neither IQ nor PhIP 
target colon in mouse carcinogenicity studies performed on the hybrid mouse 
CDFl [(BALB/Cann x DBA/2N)F,] (Ohgaki et al. 1984a, Esumi et al. 
1989), ACF induced by IQ and PhIP in mice probably do not represent an 
early stage of colon cancer. An explanation might be that PhIP and IQ are 
only weakly carcinogenic to the colon compared to other organs, and 
therefore tumours arise in the liver, forestomach and lung in the case of IQ 
(Ohgaki et al. 1984a), and in the lymphoid tissue in the case of PhIP (Esumi 
et al. 1989) long before they arise in the colon. Whether long-time feeding 
with PhIP induces tumours in other organs inci. colon in mice is yet not 
known as only the data on lymphomas have been published, and a thorough 
histological examination of this carcinogenicity study still remains to be 
reported (Esumi et al. 1989). 
In order to expand the knowledge about possible histopathological changes 
due to longer treatment time with PhIP, some of the mice from a study 
recently performed at the Institute (Sorensen et al. 1996) where mice were 
fed diets with 0.03% PhIP for seven months, were maintained for another 
11 months on control diet without PhIP (Kristiansen et al. 1997). This study 
confirmed that PhIP is a potent mouse lymphomagen and additionally 
showed that treatment with 0.03% in the diet for the first seven months of 
a life time study (18 month) gave rise to very few and sporadic tumours in 
other tissues, but none in colon, indicating weak if any carcinogenicity of 
PhIP to organs other than the lymphatic system under the study design used 
(Kristiansen et al. 1997). 
As IQ and PhIP have not been found to have colon as target organ in 
carcinogenicity studies but nevertheless induced ACF in colon of mice, the 
possible role of PhIP- and IQ-induced ACF in the development of colon 
cancer in mice was investigated by analyzing colons from mice from other 
IQ- and PhIP-studies of much longer duration for ACF (Paper VI). The 
results of these studies showed that the total number of ACF increased 
statistically significantly over time, and that the small ACF were predomi- 
nant (95- 100%) at all time-points. IQ induced ACF in a much higher number 
than PhIP, but no colon tumours were found either in IQ or PhIP dosed 
mice. As the model mouse colon carcinogens DMH and AOM have been 
shown to induce ACF with relatively high crypt multiplicity (Koratkar & 
Rao 1997, Paper IV) compared to the low crypt multiplicity (l-3 AC/Focus) 
found after IQ- or PhIP-treatment, this study could supports the hypothesis 
that the occurrence of ACF with low crypt multiplicity is probably not 
predictive for tumour outcome. 
Most recently Okonogi et al. (1997) have found that two other heterocyclic 
amines, 2-amino-9H-pyrido[2,3b]indole (A&) and 2-amino-3,8dimethyl- 
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imidazo[4,5$jquinoxaline (MeIQx), were able to induce ACF in C57BL/6N 
mice and most of the foci consisted of one or two aberrant crypts. As AC& 
and MeIQx not have been found to induce colon tumours in carcinogenicity 
studies in CDFl mice (Ohgaki et al. 1984b, 1987) the authors suggest that 
the large intestinal carcinogenicity of heterocyclic amines in mice needs to 
be re-examined using susceptible strains, such as C57BL/6N. However, our 
own examination of PhIP in C57BW6J mice fed 0.03% in the diet for the 
first 7 months of a life time study (Kristiansen et al. 1997) failed to induce 
colon tumours although ACF earlier had been detected with PhLP in this 
mouse strain (Paper IV). 
The conclusion drawn from our mouse studies was, that if cooked food 
mutagens as IQ or PhIP are to be used as initiators in the ACF test, the use 
of rats might be a better choice since: 1) in carcinogenicity studies with rats, 
colon is target organ for both IQ (Takayama et al. 1984a) and PhIP (Ito et 
al. 1991), 2) in rats induction of ACF in the colon has been demonstrated 
after both IQ (Tudek et al. 1989, Liew et al. 1995, Tachino et al. 1995, 
Ferguson & Harris 1996, Xu et al. 1996) and PhIP (Tudek et al. 1989, 
Takahashi et al. 1991, Hasegawa et al. 1993, Weisburger et al. 1994, Guo 
et al. 1995a, Ochiai et al. 1996a, 1996b), and 3) the distribution of ACF in 
the colon of IQ or PhIP dosed rats was comparable with that in rats given 
AOM or DMH-2HCl and correlated well with the distribution of tumours 
(Tudek et al. 1989, Hasegawa et al. 1993). 
Rat studies 
As IQ had been shown to induce ACF in the rat colon (Tudek et al. 1989, 
Hasegawa et al. 1993), but yet not had been used for evaluating the 
modulating effects of dietary components a rat study was initiated. With a 
feeding regimen of continuous low IQ-doses (0.03%) throughout a study 
period of 10 weeks a significant effect on the induction of the number of 
small ACF as well as total number of ACF was seen (Paper V). Additional- 
ly, it was shown that the incidence of IQ-induced ACF could be modulated 
by a diet high in refined carbohydrate. However, the fact that IQ is a rat 
colon carcinogen, together with the demonstrated induction of small and 
total number of ACF when scoring after 10 weeks, does not support the 
hypothesis that the presence of a high number of ACF with high crypt 
multiplicity is predictive for tumour outcome. Whether the effect of IQ and 
of the high carbohydrate diet on ACF induction is reflected in colon tumour 
incidence will be seen at termination of the study (data still under evalu- 
ation). 
None of the studies with IQ reported until now (Tudek et al. 1989, Liew et 
al. 1995, Tachino et al. 1995, Ferguson & Harris 1996, Xu et al. 1996) have 
examined the ACF and tumour incidence in the same experiment under the 
same conditions. Only the studies by Ferguson & Harris (1996) and Tachino 
et al. (1995) have grouped the ACF data according to size of individual 
crypts constituting each ACF. In both studies a substantial percentage of the 
IQ induced ACF contained 4 AC/focus (23% of total ACF, Tachino et al. 
1995) or >4 AC/focus (26% of total ACF, Fergnson & Harris 1996) 
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supporting the hypothesis of ACF 2 4 AC/focus being predictive for colon 
cancer. A possible explanation to the different results obtained by Tachino 
et al. 1995, Ferguson & Harris 1996 and paper V, could be that paper V 
used a continuous low dose (0.03% (wt/wt) in feed) of IQ for 10 weeks (a 
total dose of approximately 210 mg/kg), compared to Tachino et al. (1995) 
which used 130 mgjkg body weight by oral gavage on alternating days for 
2 weeks (a total dose of approximately 910 mg/kg) with ACF scoring 12 
weeks after the initial carcinogen treatment, and Ferguson & Harris (1996) 
which used three doses of IQ (50 mg/kg body weight) at weekly intervals 
(a total dose of approximately 150 mg./kg) and scoring 10 weeks after the 
first IQ treatment. 
Choice of initiator 
The choice of compound for induction of ACF and the possible effect on the 
modulating effect of test compound is illustrated by various experiments. 
Chlorophyllin (CHL) is an inhibitor of PhIP-induced ACF (Guo et al. 1995a) 
and IQ-induced rat colon cancer (Guo et al. 1995b). However, CHL neither 
decreases nor increases AOM-induced ACF (Pereira et al. 1994), and when 
DMH-2HCl is used as initiator CHL acts as a promoter of colon cancer 
(Nelson 1992). Similarly, indole-3-carbinol (13C) is an inhibitor of PhlP- 
induced (Guo et al. 1995a) and IQ-induced ACF (Xu et al. 1996), but 
enhances DMH-2HCl-induced colon carcinogenesis (Pence et al. 1986). 
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CONCLUSION 
In conclusion, the studies included in the present thesis have shown that 
ACF are induced in rodent colon by colon carcinogens such as DMH-2HC1, 
AOM, IQ, and Phil? and that the incidence of induced ACF can be 
modulated by different dietary components. 
Most of the current data from the ACF literature, and to some extent from 
the studies presented, support the evidence that some parameter(s) of the 
ACF assay do predict tumour incidence. Most of this evidence has been 
indirect: 
- ACF are induced specifically by colon carcinogens in rodents; 
- substances that promote colon cancer promote the development 
of ACF; 
- substances that inhibit development of colon cancer inhibits 
ACF formation as well; 
- genetic changes observed in colon tumours are also found in 
ACF; 
- ACF are found in the human colon in patients at increased risk 
of colon cancer. 
As no clear relation between the outcome of ACF and tumours was found 
in the present studies, the results could indicate that ACF and colon tumours 
represent two parallel independent events as a consequence of the cancer 
induction, i.e. the ACF not being preneoplastic per se. Or, the results could 
propose that only some of the ACF are precursor lesions for colon tumours 
and that the time point in the colon carcinogenic process, at which the ACF 
are scored is not the optimal for scoring a true relation between ACF and 
colon tumours. Finally the bare recording of the number of ACF and their 
crypt multiplicity is possible not sufficient to characterize the predictive 
value of ACF for tumour induction. 
To determine which is the best parameter(s) of the ACF assay in identifying 
the ACF at risk is not yet possible. The use of total number of ACF as 
parameter is not sufficient. More likely it is the number of ACF with 
multiple crypts that correlates with tumour incidence. Additional studies are 
needed to determinate the optimal parameter(s) of this assay and to further 
validate the ACF assay with test for tumour incidence, before ACF can be 
used as reliable intermediate biomarkers, and subsequently being models for 
human colon cancer. 
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Influence of a Dietary Fiber on Development of 
Dimethylhydrazine-Induced Aberrant Crypt Foci 
and Colon Tumor Incidence in Wistar Rats 
Inger Thorup, Otto Meyer, and Eva Kristiansen 
Abstract 
Formation of aberrant crypt foci (ACF) in archived colon tissue from animals in a previous 
study was examined. The animals were fed a semisynthetic casein-based diet in which the 
carbohydrate pool was substituted with a dietary beet fiber (Fibeta) as the only source of fiber. 
Oral doses of dimethylhydrazine dihydrochloride (DMH-ZHCI, 20 mg/lcg body wt) once a week 
for 10 weeks were used as initiator. The rats were fed different levels of the fiber in a preinitiation 
period, during initiation, or in a postinitiation period. 
In general, the results showed a statistically signtficant inverse relation between duration of 
intake of high-fiber diet and number of animals with ACF, as well as the total number of ACF 
and number of small ACF (1-3 crypts) per affected animal. The previously reported data showed 
no protective effect of the dietary fiber at any stage of the colorectal carcinogenic process. The 
lack of correlation between the outcome of ACF and tumors could be related to the observation 
that statistically significant differences between groups were seen only in the total number of 
ACF and number of small ACF. 
The hypothesis that ACF are preneoplastic lesions needs to be supported by further 
experimental data. The present state of knowledge could indicate that ACF represent true 
preneoplastic lesions progressing into colon tumors or that ACF and colon tumors represent two 
parallel independent events as a consequence of the cancer initiation (i.e., the ACF not being 
preneoplastic lesions per se). 
(Nutr Cancer 21, 177-182, 1994) 
Introduction 
A large number of investigations on the possible modifying effect of dietary fiber on 
experimentally induced colorectal cancer have been performed during the last decades. 
In a recent experiment in our laboratory, the modifying effect of two levels of a well-specified 
dietary fiber, Fibeta (a beet fiber), during preinitiation, initiation, and postinitiation of 
colorectal cancer has been studied in rats initiated with dimethylhydrazine dihydrochloride 
(DMH-2HCl). A protective effect of the dietary fiber was not found at any stage of the 
colorectal carcinogenic process, whereas the continuous feeding with the high-fiber diet 
resulted in a statistically significant increase in volatile fatty acids, especially butyric acid, 
which is suggested to possess anticarcinogenic properties (1). 
Aberrant crypt foci (ACF) in the colonic mucosa have been hypothesized to represent 
The authors are affiliated with the Institute of Toxicology, National Food Agency, DK 2860 
Ssborg, Denmark. 
Copyright 0 1994, Lawrence Erlbaum Associates, Inc. 
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precursor lesions of chemically induced colon cancer. Aberrant crypts can be identified by 
their increased size, thicker epithelial lining, and increased pericryptal zone (2-S). 
Few experiments have been designed to determine whether the early detection of ACF 
corresponds to the later development of tumors (7, g--13), and very few studies have been 
performed to elucidate the effect of dietary fiber on aberrant crypt formation (13, 14). 
To investigate whether the intake of different levels of the dietary fiber in our previous 
study design was reflected in the presence of ACF, archived colon tissue from all animals in 
the previous study (1) was examined. 
Materials and Methods 
Animals 
Three-week-old male Wistar rats [Mol:WIST(SPF), Mollegard Breeding Center, Ll. 
Skensved, Denmark] were assigned to nine groups after a two-week acclimatization period, 
according to Table 1. 
Experimental Design 
The animals were dosed with DMH-2HCl (20 mg/kg body wt; Sigma Chemical, St. Louis, 
MO) or solvent (0.9% NaCl solution) by gavage (5 ml/kg body wt) once a week for 10 weeks. 
Throughout the experiment (1 yr), the rats were given a powdered semisynthetic casein diet 
(15) in which the carbohydrates (cornstarch, potato starch, dextrin, and sucrose) were 
substituted with a dietary fiber (Fibeta) as the only source of fiber. The levels of Fibeta in 
the diets offered to the rats at the different periods during the study are presented in Table 
1. The levels of Fibeta correspond to 0.7% and 14% dietary fiber in the rat diet. Fibeta consists 
of approximately 70% dietary fiber, 9% protein, 5% sucrose, 1% starch, 1% fat, and 5% ashes 
and water. A detailed description of the experimental condition and design, including analysis 
of the dietary fiber, has been given previously (1). 
After one year, all animals were necropsied, and selected organs were fixed in 4% neutral 
buffered formaldehyde for histopathological examination. Before fixation, the large intestine 
was cut longitudinally, rinsed in 0.9% NaCl solution, cut into four pieces, and pinned on a 
cork slab. The divisions were made in the light of anatomic conditions based on the principles 
outlined by Lindstriim (16): the proximal colon (7 cm), the major flexure (5 cm), the distal 
colon (6 cm), and the residual colorectal segment (which varied in length). 
Table 1. Experimental Design 
% Fibeta in Diet 
DMH-2HC1, b 
Group No. ti 8 Wks Preinitiation 10 Wks Initiation 30 Wks Postinitiation mg/kg Body Wt 
I 60 
II 30 
III 30 
IV 30 
V 30 
VI 30 
VII 30 
VIII 30 
IX 30 
1 
1 
20 
20 
20 
20 
1 
1 
1 
1 
1 
1 
20 
20 
20 
20 
1 
20 
1 
1 
1 
1 
20 
20 
1 
20 
20 
0 
20 
20 
20 
20 
0 
20 
20 
20 
a: No. of rats. 
b: Dimethylhydrazine dihydrochloride (DMH-2HCl) was given once. a week for 10 wks. 
178 Nutrition and Cancer 1994 
57 
IdentiJication and Quantification of ACF 
The histopathological data from the previous study revealed that the majority of the induced 
tumors were located in the proximal colon and major flexure (1). Inasmuch as other studies 
at our institute show that ACF are not seen in the proximal colon at different times after 
DMH initiation, the major flexure was selected for the examination for ACF. The middle 1.5 
cm was selected for scoring. Giemsa stain (6 ml of concentrate in 50 ml of phosphate-buffered 
saline, pH 7.1, for 30 min) was used to visualize the ACF, and excess stain was rinsed off 
with phosphate-buffered saline. The tissue was placed luminal side up in a Petri dish with 
enough phosphate-buffered saline to cover the tissue, because we experienced that this 
procedure reduced the reflected light and made the scoring easier. The number of ACF and 
the number of aberrant crypts per focus were recorded blindly using a stereo microscope at 
x40 magnification. The aberrant crypts were distinguished by their increased size, thicker and 
deeply stained epithelial lining, and increased pericryptal zone compared with normal crypts 
(4). An ACF may consist of one to several crypts, and in the present study the ACF were 
grouped into small (1-3 crypts), medium (4-6 crypts), and large (27 crypts) foci, respectively. 
Statistics 
Fisher’s exact (2-tailed) test was used to compare the incidence of ACF between groups. 
Because of lack of normality of the data (Shapiro-Wilk), the comparison of total number and 
distribution of ACF with various numbers of crypts between groups was conducted by 
Wilcoxon rank-sum test when two levels were compared and Kruskal-Wallis test when more 
levels were compared. A probability of 15% was considered significant. All statistical 
calculations were carried out using SAS Release 6.03 (1988). 
Results 
Body weight, food consumption, clinical appearance, and tumor incidence data have been 
reported previously (1). Neither ACF nor tumors were observed in animals given 0.9% NaCl 
solution (Groups I and VI, data not shown). The values in Table 2 show a statistically 
significant lower number of rats with ACF in groups fed the high-fiber diet for 40 or 48 weeks 
than in groups fed the high-fiber diet for 0, 8, or 18 weeks. 
The total number of ACF and the distribution of small, medium, and large foci per affected 
animal are presented in Table 3. Statistically significant differences in total number and 
number of small foci between some of the groups were seen. When pairwise comparisons of 
Table 2. Influence of High-Fiber Diet on Number of Rats With ACF and Tumors 
and Comparison of Outcome of ACF and Colon Tumors04 
Total Time 
No. of Animals With 
Group No. n on HFD, Wks ACF Tumor ACF and tumor 
II 30 0 20 (67) 8 (27) 3 
III 30 8 23 (77) 7 (23) 6 
IV 29 18 23 (79) 6 (21) 6 
V 30 48 11 (37)* 9 (30) 2 
VII 30 10 15 (50) 9 (30) 8 
VIII 29 30 12 (41) 8 (28) 3 
IX 29 40 8 (28)* 4 (14) 0 
a: All animals were dosed with DMH-2HCl. 
6: Abbreviations are as follows: HFD, high-fiber diet; ACF, aberrant crypt foci. 
c: Values in parentheses are percent. 
d: Statistical significance is as follows: *, different from Groups II, III, and IV (Fisher’s exact test, p I 0.05). 
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! Table 3. Influence of High-Fiber Diet on Number of ACF in Rats and Distribution 
of ACF According to Number of Crypts in Focus 
No. of Foci/Colonkd 
Group No. na Total Small Medium Large 
II 20 11.2 z!z 2.6 6.0 k 1.7 3.8 f 0.9 1.4 * 0.5 
III 23 9.3 k 2.5 5.8 k 1.6 2.3 i 0.8 1.3 * 0.3 
IV 23 10.5 k 2.5 5.8 ‘- 1.4 2.9 t 0.8 1.7 k 0.5 
V 11 4.4 f 1.1* 1.7 * 0.4* 1.4 * 0.4 1.3 ?I 0.4 
VII 15 3.3 5 1.9* 2.0 k 1.3* 0.9 t 0.5* 0.4 + 0.2 
VIII 12 6.3 f 2.2 3.3 -c 1.1 2.0 f 0.8 1.0 k 0.5 
IX 8 3.8 z?z 1.4* 2.0 f 0.9* 1.3 i- 0.5 0.5 + 0.3 
a: No. of affected animals. 
b; Values are means + SE. 
c: Small foci. l-3 crypts; medium foci, 4-6 crypts; large foci, 27 crypts. 
d: Statistical significance is as follows: *, significantly less than Group II (Wilcoxon rank-sum test, p < 0.05). 
1 
number of total and small foci were made between groups, statistically significant differences 
were observed between rats fed low-fiber diet and those fed high-fiber diet for 10, 40, and 48 
weeks, respectively. 
It appears from Table 2 that no consistency exists between the presence of ACF and colon 
tumors. On the basis of individual animal findings, no correlation could be established between 
high numbers of ACF and presence of colon tumors (data not shown). 
Discussion 
In the previous study, no effect of the dietary fiber was found at any stage (preinitiation, 
initiation, and postinitiation) of the development of DMH-induced colorectal cancer (1). When 
the archived colon tissue from the same study was analyzed for ACF, a modulating effect of 
the dietary fiber was observed, and the data showed a correlation between intake of high-fiber 
diet and the presence of DMH-induced ACF. 
In general, the values showed an inverse relation between duration of intake of high-fiber 
diet and incidence of rats with ACF as well as total number and number of small ACF per 
affected animal. The data for Group VII, those who received the high-fiber diet only during 
the lo-week initiation period, do not follow the pattern of the data for the other groups in 
relation to duration of intake of high-fiber diet. No plausible explanation can be given. If the 
data reflect a specific effect of dietary fiber when given during the initiation period, a similar 
effect would have been expected for Group IV, who received high-fiber diet in the preinitiation 
and initiation periods. 
The ACF found in this experiment cannot directly be characterized as a precursor of colon 
cancer, inasmuch as the experimental design did not include interim sacrifice. However the 
DMH-induced ACF in the present study are similar to those found in other studies at our 
institute as well as those described in the literature as possible early markers of colon cancer. 
Two other studies of ACF in relation to dietary fibers showed a reduction in ACF after 
feeding azoxymethane-induced rats flaxseed supplementation (14) or a low-risk diet that was 
high in fiber and calcium and low in fat (13). A third study with a different complex 
carbohydrate mixed in a Western-style diet showed that starch had no influence on the total 
number of foci induced by DMH but was able to reduce the number of affected crypts per 
focus (17). 
Accumulating evidence supports the hypothesis that the development of ACF in laboratory 
animals and humans is indicative of a potential carcinogenic effect in the large bowel (18-21). 
The previously reported data from our experiment showed that a continuous feeding of rats 
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with a high-fiber diet resulted in increased production of intestinal volatile fatty acids, 
especially butyrate (1). Thus the demonstrated increase in production of butyrate and the 
reduction in ACF could indicate a protective effect of the beet fiber on the development of 
colon cancer in rats. However, these findings were not reflected in the colon tumor incidences 
previously obtained (1). 
It has been proposed that ACF represent a preneoplastic lesion of colon cancer (2-8), and 
recent studies indicate an activation of the ras oncogene in azoxymethane-induced ACF and 
adenocarcinomas in rats, which points toward a preneoplastic nature of the ACF (22,23). The 
results from the present study, when assessed in terms of individual animal findings, did not 
show any correlation between occurrence of ACF and tumors. Only part of the major flexure 
of colon has been scored for ACF in this study. However, data from experiments at our 
institute have shown that the majority of the ACF are located in the major flexure. In addition, 
it should be borne in mind that the data derive from a large number of animals. 
The distribution of ACF (Table 3) indicates that the differences in total number of ACF, 
to a great extent, are reflected in the number of small foci (l-3 crypts), which constitute the 
major part of the ACF. A minor change in medium-sized ACF (4-6 crypts) similar to that 
of the small foci is seen as well. Our studies did not reveal any intergroup difference in number 
of large foci or tumor incidence of colon. Earlier studies (7,12) showed that tumor development 
was correlated only with the larger foci and not with the total number of ACF. The lack of 
correlation between ACF and tumors in our study could be related to the observation that a 
statistically significant difference between groups was seen only in the number of total and 
small foci. 
The hypothesis that ACF are preneoplastic lesions needs to be supported by further 
experimental data. The present state of knowledge could indicate that ACF represent either 
true preneoplastic lesions progressing into colon tumors or that ACF and colon tumors 
represent two parallel independent events as a consequence of the cancer initiation (i.e., the 
ACF not being preneoplastic lesions per se). 
New studies are in progress in our laboratory to further elucidate the modulating effect of 
different diets by sequential analysis of selected intermediate markers in relation to develop- 
ment of colon cancer. 
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Influence of Different Diets on Development of 
DMH-Induced Aberrant Crypt Foci and Colon 
Tumor Incidence in Wistar Rats 
Eva Kristiansen, Inger Thor-up, and Otto Meyer 
Abstract 
The present study was undertaken to investigate certain dietary factors known to affect the 
development of colon cancerfor their ability to modulate aberrant crypt foci (ACF). Male Wistar 
rats were initiated with oral doses of dimethylhydrazine dihydrochloride (DMH-2HC1, 20 mglkg 
body wt) once a week for IO or 20 weeks. Throughout the study the animals were fed 1) 
semisynthetic casein-based control diet, 2) control diet with 2O?? lard, 3) control diet with 20% 
lard and 2076 dietary fiber, or 4) control diet where most of the carbohydrate pool was substituted 
with sucrose and dextrin. The composition of the different diets was designed to achieve equivalent 
intakes of essential nutrients. Animals were killed after IO, 20, and 31 weeks. 
The study showed a pronounced effect of dietary composition on the development of DMH-in- 
duced ACF. The diet high in sucrose and dextrin caused a statistically significant increase 
(p I 0.05) in the total number of ACF and number of small and medium ACF. Adding lard to 
the standard diet did not cause an increase in ACF, but if the dietary fiber was added to the 
high-fat diet, a statistically significant reduction (p S 0.05) in the total number of ACF and 
number of small and medium ACF was observed. The values of large and extra-large foci reflected 
the same effect of diets on ACF. 
The results indicate that tumors in the group fed the diet high in refined carbohydrates were 
more prominent and occurred with a higher incidence. However, the dtfference is based on few 
tumors and is not statistically significant. Our results do not show that the number of ACF and 
crypt multiplicity are conclusively predictive for tumor outcome with the present protocol, which 
did not include parameters to differentiate between ACF at the cellular level. 
(Nutr Cancer 23,151-159, 1995) 
Iutroduction 
Accumulating evidence supports the hypothesis that the development of aberrant crypt foci 
(ACF) in laboratory animals and humans is indicative of a potential carcinogenic effect in 
the large bowel (l-4). 
It has been proposed that ACF represent a preneoplastic lesion of colon cancer (S-l l), and 
the ACF assay has been used by several investigators to study dietary modulators of colon 
carcinogenesis (8,12-l 8). 
Previously, we reported an inverse relation between intake of a high-fiber diet and the 
incidence of dimethylhydrazine (DMH)-induced ACF (19). However, no effect of the dietary 
fiber was found at any stages of the development of colorectal cancer (20). 
The authors are affiliated with the Institute of Toxicology, National Food Agency, DK 2860 
Serborg, Denmark. 
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The objective of the present study was to further investigate the effect of the dietary fiber 
on the ACF outcome and the correlation between ACF and tumor incidence in DMH-induced 
Wistar rats. In addition, the effects of other dietary macronutrients were investigated. Three 
different diets were tested: 1) a high-fat-low-fiber diet corresponding to the diet consumed by 
the Western populations with a high incidence of colorectal cancer, 2) a high-fat-high-fiber 
diet, and 3) a diet rich in sucrose and dextrin, reflecting the relatively high content of refined 
carbohydrates in the Western diet. 
The experimental design, where the respective diets were fed during and after dosing of 
DMH, reflects the consumer situation where the initiation and promotion often will take place 
simultaneously. 
Materials ad Methods 
One hundred thirty-two three-week-old male outbred rats mol:WIST(SPF)] were purchased 
from Molleg&rd Breeding Center (Ll. Skensved, Denmark). 
Diets 
The composition of the different diets is given in Table 1. Animals in Group I received the 
basic semisynthetic diet based on the formula given by Meyer and co-workers (21). In the 
Group II diet, the carbohydrate pool was reversed from 90% starches and 10% dextrin and 
sucrose to loo/o and 90%, respectively. In Groups III and IV, animals received the basic diet 
in which 20% of the carbohydrate pool was replaced by lard (Group III) or 40% was replaced 
by 20% lard and 20% beet fiber (Group IV). The latter diets were adjusted to provide the 
animals in all groups with equal dietary intake of protein, vitamins, and minerals per calorie 
diet. 
The beet fiber (Fibeta, De Danske Sulckerfabrikker, Nakskov, Denmark) was identical to 
that used in earlier studies (19,20), and the 20% corresponds to 14% dietary fiber in the rat 
diet. The fat was fully refined lard (Dafoma, Unilever, Sonderborg, Denmark). 
1 Table 1. Composition of Diets 
I 
Group 
II III Iv 
Na+zeinate, % 
Carbohydrate mix 1: % 
Carbohydrate mix 2,b % 
Soya hean oil (with vitamins A, D, and E), % 
Mineral mixture, % 
Vitamins B and K, choline chIoride, inositol, 
and methiolline, % 
cellulose, % 
Lard, % 
F&eta,= % 
Caloric density,” kcal/g 
20 20 
67 
67 
4 4 
3.3 3.3 
1.4 1.4 
4 4 
3.9 3.9 
26 25 
42 23 
5 5 
4.3 4.1 
1.8 1.7 
1.4 
20 
5.0 
2 
20 
20 
4.7 
CL‘ Carbohydrate mix 1: 45% cornstarch, 45% potato starch, 5% sucrose, 5% dextrin. 
b: Carbohydrate mix 2: 5% cornstarch, 5% potato starch, 45% sucrose, 45% dextrin. 
c: For specScation see Ref. 20. 
d- Calculation is as follows: fat = 9 kcallg, protein = 4 kcallg, carbohydrate = 4 kcallg, Fibeta = 3 kcallg. 
152 
64 
Nutrition and Cancer 1995 
Chemical 
1 ,ZDimethylhydrazine dihydrochloride (DMH-2HCI) was obtained from Sigma Chemical 
(St. Louis, MO). 
Housing 
The animals were kept in disposable plastic cages with an inserted steel grid floor, two 
animals per cage, in flexible film isolators (Isotec 12134, Olac, Oxford, UK) during the l-week 
predosing period, the lo- or 20-week dosing period, and 2 weeks after termination of the 
dosing with DMH-2HCl. For the remaining period of the study, the animals were kept in 
stainless steel wire cages, two animals per cage. During the study, the temperature was 
maintained at 22 + 1°C and relative humidity at 55 C 5%, air was changed 8-10 times/hi-, and 
fluorescent light was on from 2100 to 0900. 
Experimental Design 
The animals were randomly assigned to the four experimental groups. The animals were 
dosed with DMH-2HC1(20 mg/kg body wt) by gavage (5 ml/kg body wt) once a week for 10 
weeks (10 animals/group) or 20 weeks (18 or 28 animals/group) according to Table 2. 
Body weight and food and water consumption were measured weekly. Interim sacrifices 
were performed after 10 weeks (10 animals/group) and 20 weeks (8 animals/group). The rest 
of the animals were sacrificed after 31 weeks. Complete gross necropsy was performed on all 
animals, and the large intestine was examined histopathologically. Before fixation, the large 
intestine was cut longitudinally, rinsed in 0.9% NaCl solution, and divided into four pieces. 
The first segment comprised the proximal colon with the herring bone mucosal structure; the 
remaining part was divided in three parts of equal size. The colon segments were pinned on 
a cork slab and fixed in 4% neutral buffered formaldehyde. After fxation, Giemsa stain (6 
ml of concentrate in 50 ml of phosphate-buffered saline, pH 7.1, for 15 mins) was used to 
visualize the ACF, and excess stain was rinsed off with phosphate-buffered saline. The tissue 
was placed hnninal side up in a petri dish with enough phosphate-buffered saline to cover the 
tissue. The number of ACF and the number of aberrant crypts per focus were recorded using 
a stereomicroscope at x40 magnification. The aberrant crypts were distinguished by their 
increased size, thicker and deeply stained epithelial lining, and increased pericryptal zone 
compared with normal crypts (7). An ACF may consist of one to several crypts, and in the 
present study the ACF were grouped into small (l-3 crypts), medium (4-6 crypts), large (7-9 
crypts), or extra-large (110 crypts) foci. 
Colon tissue deviating from normal morphology at gross examination was embedded in 
paraffin, sectioned (4-6 ),rm), and stained with hematoxylin and eosin for microscopic exami- 
nation. The size and distribution of all colon tissue changes were registered. 
Table 2. Experimental Design&b 
20 Wks Initiation + 
Group 10 Wks Initiation 20 Wks Initiation 11 Wks Postinitiation 
I 10 8 10 
II 10 8 10 
III 10 8 20 
IV 10 8 20 
a.- Dimethylhydrazine dihydrochloride (DMH-ZHCI), 20 mg/kg body wtlwk. 
b: Values are expressed as no. of rats. 
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Statistics 
One-way analysis of variance was used to analyze body weight, weight gain, and food and 
water consumption. A test for normal distribution (Shapiro-Wilk) of ACF data was carried out 
on logarithmically transformed data. Two-way analysis of variance (diet x time) on the logarith- 
mically transformed data was used to determine the effect of diet on the ACF over all time points. 
(One-way analysis of variance was used for analyzing each time point separately.) Duncan’s 
multiple range test was used for pairwise comparisons. Fisher’s exact (2-tailed) test was used to 
determine the effect of diet on tumor incidence. A probability of 55% was considered significant. 
All statistical calculations were carried out using SAS release 6.04. 
Body Weight and Food and Water Consumption 
During the experiment, no treatment-relatedsigns of adverse effect in clinical appearance 
of the animals were observed. A statistically significant increase in average body weight during 
the entire experimental period was seen in Group III animals offered the 20% fat diet compared 
with the other groups. No other treatment-related changes were observed in body weights. 
The data for food consumption (not shown) revealed a consistently lower average weekly 
intake during the entire experimental period for animals fed the 20% lard diet (Groups III 
and IV) and a lower average weekly intake during the first one-third of the study for animals 
fed the diet low in starches and high in dextrin and sucrose (Group II) than for Group I. The 
lower values for average weekly food intake for Group II were reflected in the values for 
average energy intake in kilocalories per animal per week (3-16% lower than Group I). The 
corresponding values for Group IV animals were statistically significantly lower in a few 
experimental weeks than for Group III (<loo/o apart from Weeks 23 and 24, where values 
were 15% and 11% lower, respectively). A comparison of the data for Groups I and III revealed 
no consistent difference in average energy intake. No consistent treatment-related changes 
were observed in water consumption. 
ACF 
The total number of ACF and distribution of ACF are presented in Table 3. Two-way 
analysis of variance demonstrated a significant effect of diet on total number of ACF and 
number of small and medium ACF over all time points. Significant effect of time was seen 
with respect to total number of ACF and number of medium ACF. Because of a small number 
of large and extra-large foci in some of the groups, lack of normality of these data was found, 
and therefore analysis of variance was not applied, but the effect of diet and time on these 
ACF was the same (Table 3). The total number of ACF and distribution of ACF between 
groups showed the same effect with respect to diet when analyzed at each time point (data 
not shown). 
Highly refined carbohydrates (Group II) significantly increased the number of ACF, whereas 
the dietary fiber (Group IV) caused a significant decrease in ACF. A schematic illustration 
of development of ACF with respect to diet and time is given in Figure 1. From Table 3, it 
appears that the relative distribution of small, medium, large, and extra-large ACF is similar 
among groups. 
Tumors 
No tumors were observed 10 weeks after the start of dosing (data not shown). Tumors were 
observed 20 and 31 weeks after the start of dosing, but no statistically significant difference 
in incidence between groups was seen (Table 4). No tumors were observed in animals given 
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Table 3. Influence of Different Diets on Number of ACF in Rats and Distribution of 
ACF According to Number of Crypts in Focus 
ACFIColon”” 
Wks n Group Small Medium Large X-large Total 
10 10 I 70.5 + 18.8 (87) 9.5 I 4.2 (12) 0.8 i 0.2 (1) 0.0 I 0.0 (0) 80.8 122.8 
10 II 197.0 z!z 36.3 (91) 18.6 + 4.9 (8) 1.1 i 0.4 (1) 0.2 + 0.1 (0) 216.7 f 39.6 
IO III 109.6 + 49.1 (93) 7.2 f 4.7 (6) 0.6 zk 0.5 (1) 0.0 k 0.0 (0) 117.4 i 53.6 
10 IV 40.7 It 12.9 (90) 4.2 f 1.5 (9) 0.3 + 0.2 (1) 0.1 + 0.1 (0) 45.2 Jr 14.2 
20 8 I 108.0 5 21.7 (81) 21.1 F 5.5 (15) 3.5 i 1.3 (3) 0.9 f 0.5 (1) 133.5 + 26.8 
8 II 366.1 i 72.6 (69) 121.3 f 29.4 (23) 27.0 i 10.2 (5) 13.6 f 9.5 (3) 528.0 f 113.4 
8 III 102.0 + 37.9 (88) 13.0 +- 4.5 (11) 0.9 * 0.4 (1) 0.4 + 0.2 (0) 116.3 i 42.7 
8 IV 48.9 k 30.0 (82) 10.3 F 6.9 (17) 0.6 + 0.4 (1) 0.3 * 0.2 (0) 60.0 f 37.4 
31 9 I 110.7 i 31.2* (66) 42.8 i 9.1* (26) 10.4 i 1.9 (6) 3.0 f 0.8 (2) 166.9 f 40.0* 
9 II 318.2 -f 64.9t (66) 120.9 i 25.8t (25) 28.9 5 7.2 (6) 11.8 f 4.6 (3) 479.8 f 89.2t 
18 III 122.7 f 35.2* (79) 26.6 f 5.1* (17) 5.3 f 1.1 (3) 1.5 i 0.6 (1) 156.1 i 40.4* 
20 IV 50.6 +- 15.4$ (67) 19.3 f S.O$ (25) 4.7 f 2.0 (6) 1.6 f 0.6 (2) 76.1 + 25.6$ 
Statistical significance (2-way analysis of variance, P values) 
Diet 0.0001 0.0001 0.0001 
Weeks 0.2057 0.0001 0.0134 
Weeks x diet 0.8469 0.2702 0.7773 
~1; Values are means rt SE; nos. in parentheses represent percentage of total; n, effective no. of rats. ACF, aberrant 
crypt foci. 
b: Small foci, l-3 crypts; medium foci, 4-6 crypts; large foci, 7-9 crypts; X-large foci, 210 crypts. 
c: Groups not sharing a common superscript (*. t, $) differ significantly by Duncan’s multiple range test @  I 0.05). 
Table 4. Influence of Different Diets on Incidence of Colorectal 
Tumors in Rats” 
Group 
Time After Dosing 
20 wks 31 wks Total B 
I 2i8 (25) 4110 (40) 6118 (33) 
II 3/S (38) S/10 (80) 11118 (61) 
III 118 (13) 12/20 (60) 13/28 (46) 
IV O/8 (0) 14120 (70) 14128 (50) 
u: Values are expressed as no. of affected animals/total no. of animals; values in paren- 
theses are percentages. 
the high-fiber diet at 20 weeks. At both sacrifices, the highest tumor incidence was seen in 
Group II, in which a greater part of the tumors appeared large (210 mm diam), reddish, and 
cauliflower-like. When assessed on the basis of individual animal findings, no correlation 
between occurrence of ACF and tumors (data not shown) could be found. 
DiSCUSSiOll 
The composition of the diets was designed to achieve equivalent intakes of essential nutrients 
on the basis of the assumption that rats would consume equivalent energy from each of the 
diets, even though concentrations of macronutrients would differ. Irrespective of equivalent 
energy intake for Groups I and III, the weight gain of the animals in the latter group fed 20% 
lard was significantly higher. This observation is in accordance with that of Malville-Shipan 
and Fleming (22). The lower energy intake in the animals fed the diets high in dextrin and 
sucrose (Group II) or the 20% beet fiber diet (Group IV) did not result in lower weight gain 
than in those receiving the basic diet (Group I) and was not considered to interfere with the 
nutrient requirement of the animals. 
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Number of ACF/colon 
Small Medium Large X large Total 
Figure 1. Influence of different diets on development of dimethylhydrazine-induced aberrant crypt foci (ACF) in 
rats at 3 time points. Diet I, basic diet; Diet II, high-sucrose/dextrin diet; Diet III, high-fat diet; Diet IV, high-fat/high- 
fiber diet. Small foci, 1-3 crypts; medium foci, 4-6 crypts; large foci, 7-9 crypts; X-large foci, 210 crypts. 
The present investigation showed that a diet high in refined carbohydrates caused a 
statistically significant increase in the number of ACF. Adding lard to the standard diet did 
not cause an increase in ACF, but if the beet fiber was added to the high-fat diet, a statistically 
sign&ant reduction in ACF was observed. 
High content of refined carbohydrates caused a statistically significant increase in total 
number of ACF and number of small and medium ACF. The high-fat diet did not affect the 
number of ACF, inasmuch as no statistically significant difference could be detected between 
Groups I and III. Adding dietary fiber (Group IV) to the high-fat diet (Group III) caused a 
statistically significant decrease in total number of ACF and number of small and medium 
ACF. Even though statistical analysis was not applied to the data on large and extra-large 
foci, the values reflect the same effect of diets on ACF. 
In Group I, the carbohydrate pool mainly consisted of starches (Table 1). Analysis showed 
that approximately 55% of the potato starch and 7% of the cornstarch was resistant starch 
(23), which physiologically may act as a dietary fiber. The smaller number of ACF in Group 
I than in Group II could be interpreted as a consequence of a fiber-like effect of starches 
similar to the effect obtained by adding dietary fiber to the diet in Group IV. It could be 
speculated that the effect is caused by the specific fiber used or that the effect is a consequence 
of the lower dietary intake of calories of the high-fiber fed animals. However, the latter 
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explanation is not supported by the data for Group II animals having a high number of ACF 
irrespective of the relatively low caloric intake. 
The observed modulation of refined carbohydrates on development of ACF is in accordance 
with results obtained by other investigators. In DMH-induced rats, Caderni and associates 
(12) found that a high-sucrose diet caused a significant increase in the percentage of large 
ACF (3-6 crypts) and a reduction in percentage of small ACF (l-2 crypts) compared with a 
high-starch diet. Stamp and colleagues (24) compared the effect of certain refined sugars 
(sucrose, glucose, fructose) on ACF in azoxymethane (AOM)-induced mice. The results 
demonstrated that oral gavage of sucrose and fructose led to a significant increase in number 
of ACF, whereas glucose did not. Furthermore case-control studies indicate that refined sugar 
may be a risk factor for human colorectal cancer (25-29). 
Previously, we showed a statistically significant inverse relation between duration of intake 
of a high-fiber diet and number of animals with ACF as well as the total number of ACF and 
number of small ACF (l-3 crypts) per affected animal (19). Similar results have been obtained 
by others. A reduction in ACF after feeding AOM-induced rats flaxseed supplementation (16) 
or a low-risk diet high in fiber and calcium and low in fat (15) has been shown. In a study by 
Hardman and others (14), DMH-induced rats fed diets with pectin and corn oil added had 
significantly fewer total ACF and medium ACF (4-6 crypts) per rat than rats fed a fiber-free 
diet with no corn oil added. 
The present study did not support the modulating effect of a high-fat diet on the development 
of ACF shown in other studies. Shivapurkar and co-workers (15) showed that AOM-induced 
rats on a high-risk diet, high in fat and low in fiber and calcium, had a higher number of ACF 
than those fed a low-risk diet. Similar findings have been reported by McLellan and Bird (8), 
who found that AOM-induced mice fed a high-fat diet had more ACF per colon and larger 
mean size of the ACF than those fed a low-fat diet. 
The relative distribution of ACF categorized by crypt multiplicity is similar between groups, 
whereas the absolute number of ACF for all categories is very much higher in Group II. The 
DMH dose regimen employed in the present study implies that the data mirror the influence 
of the different diets on the development of ACF and tumor during initiation and promotion. 
This regimen reflects the consumer situation, in which initiation and promotion take place 
simultaneously. 
The number of small ACF increases after 10 and 20 weeks in all groups, revealing a constant 
induction of small ACF during the 20 weeks of DMH administration. The corresponding 
values for the medium, large, extra-large, and total ACF show a constant increase in number 
during the entire period except in Group II. The data concerning Groups I, III, and IV indicate 
a continuous development in size of ACF. The different development pattern of medium, 
large, and extra-large ACF in Group II animals receiving the diets high in sucrose and dextrin 
could be hypothesized as being a result of a cocarcinogenic effect of sucrose and dextrin on 
the DMH induction of ACF and consequently an initial induction of a very high number of 
ACF, leading to a biologic saturation of the capacity of the intestinal epithelium for further 
development of ACF. 
No statistically significant differences in tumor outcome (benign or malignant) were seen 
among the groups. The most prominent tumors were seen in Group II, in which the number 
of aberrant foci with four or more crypts was very high. Earlier studies (10,30,31) found crypt 
multiplicity to be a better predictor of tumor outcome than the total number of ACF. Even 
though our results indicate a correlation between ACF and tumors, they are not able un- 
equivocally to support the theory that the presence of a high number of ACF with high crypt 
multiplicity is predictive for tumor outcome. The absence of correlation might be related to 
the rather low tumor incidence. 
When assessed on individual animal findings, no correlation between occurrence of ACF 
and tumors could be found. In fact, some of the most prominent tumors were found among 
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animals with no or few aberrant foci with four or more crypts. That the number of ACF and 
crypt multiplicity were not predictive for tumor outcome has also been reported by Hardman 
and co-workers (14). 
In conclusion, the study showed that the dietary composition has a pronounced effect on 
development of DMH-induced ACF. Even though the tumors in Group II were more 
prominent and occurred with somewhat higher incidence, the overall tumor picture did not 
unequivocally support the ACF data. In addition, there was a lack of correlation between the 
occurrence of ACF and tumors in the individual animals. 
Recent investigations (32-34) revealed ACF as a heterogeneous group of lesions. The present 
study did not include parameters to differentiate between ACF at the cellular level, but our 
results do not show that the number of ACF and crypt multiplicity are conclusively predictive 
for tumor outcome. 
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Effect of Potato Starch, Cornstarch and Sucrose on Aberrant Crypt 
Foci in Rats Exposed to Azoxymethane 
INGER THORUP. OTTO MEYER and EVA KRISTIANSEN 
Abstract. Strdk i7a1~ .s170~:17 ti7ut tli&wt7t kir7d.s o/ 
c~illho~l~(i~(lt~.~ al? 1ihle to I~7Odj~ the rle\dopnlellr 01’ do-rectal 
cntw~’ i/7 min7ctl.s us ~~11 (IS /7111771117.s. It7 the pwsu7t .SILIC~J with 
M/S .s~i~‘iu.s~ cit7tl lwo lyy7f.s 01’ starcl7e.s wfre ii7lvstigutfd ,/or- their 
#&IS 017 I/W de~dop1~7er7t o/‘ N~~I.L~I~I uypt [oci (ACF). wizich 
iiat~, 1~17 prqix~sefl iv i-~pimeni pset7eoplutic 1e.rion.s q/’ colo- 
wctctl ~1117~~ Fifty-.siy ~hrre-week-old mule Wistar I’LII.S were 
12117d01771~ assig~7etl to ,roLlr gro11p.s ~7tl dosed ,SU~~W~~~LLS~J 
with AOM 115 m,:‘ilis’ ho@ wt) 0~7~~ N week Jar 2 weeks. At the 
e17tl of’ the dosing period the u7ii77al.s were rillocateci to their 
rz.sp&ti~~e diets. Group 1 wus fed tl7e basic diet: it7 Group II the 
carhohyiratr pool iI7 the diet was repl~~cecl by .sucrose. iI7 Group 
1II by potllto starch 1117d in Gro~q IV b! cor77.siarcl7. Atzirnals 
receivii7g the pottrlo .stmd7 diet showed N .statistical!~ .sigfzificar7t 
red~rctio17 it7 body weigl7t guil7. A stati.sticcllJy .sig~zificantly lower 
17111771~~ of ACF it7 (111 cutegorie.s brr; .small wese cie~no~7str~~trcl in 
at7imuls give17 potllto starch. m7cl it7 ulditior7 (117 ejjeect wns .seen 
in the relative distribrltio~7 oj’ACF wit17 fewu qf the lqyr ACF. 
No effect of sucrose or co1-t7.stnrch was seet7. Explanatio/zs oJ‘ 1I7e 
inhibitory Effect in the potcrlo starch group 017 fhe developmeat of 
ACF coulcl either be the lower daily caloric it7tnke or tl7e 
substnntinl nlnoLrnts of resistant starch in the potato starch used. 
Studies during the last years have shown that a significant 
amount of starches escapes digestion in the small intestine (l- 
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3). These starches. called resistant starches. may reach the 
large intestine and are here available for fermentation like 
dietary) fibres. Like dietary fibres. resistant starches may be 
important as a protective factor in human cola-rectal cancer 
(3-h). In contrast to this effect. recent data have shown that 
refined sugar may be a risk factor for development of this 
lesion (7-11). 
Experimental studies have shown that cornstarch may 
inhibit some of the steps in intestinal carcinogenesis in 
azoxvmethane-induced rats (12) and decreases the 
dimensions of dimethylhydrazine-induced aberrant crypt foci 
(ACF) in the colon (13). ACF have been proposed to 
represent preneoplastic lesions of cola-rectal cancer (14-X). 
Previous studies from our laboratory have shown that a diet 
rich in refined carbohydrates increases the number and/or 
size of aberrant crypt foci (ACF). whereas a high-fibre diet 
showed the opposite effect (31.23). The inhibitory effect of 
dietary fibre on the formation of ACF has also been 
demonstrated by Alabaster ci al (23). 
In the present study we have investigated the effect of 
sucrose and two different types of starches on the 
development of azoxymethane-induced ACF in male Wistar 
rats. The starches tested were a potato starch with very high 
amounts of resistant starch and cornstarch with only low 
amounts. 
Materials and Methods 
A~zb7znls. Fifty-six three-week-old male outbrcd rats [Mol:WIST(SPF)] 
were obtained from MQllegird Breeding Center. (LI. Skensved. 
Denmark). 
Diers. The composition of the different diets is siven in Table I. Animals 
in Group I received the basic semisynthetic diet based on the formula 
given by Meyer E/ al (24). In the Group II diet the carbohydrate pool was 
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replaced by sucrose, in Group III by potato starch and in Group IV by 
cornstarch. 
Chemical. Azoxymethane (AOM) was obtained from Sigma Chemical 
(St. Louis, MO). 
Housing. The animals were kept in disposable plastic cages with an 
inserted steel grid floor, two animals per cage, in flexible fi lm isolators 
(Isotec 12134, Olac, Oxford, UK) during the l-week predosing period, 
the 2-week dosing period, and for 2 weeks after termination of the 
dosing with AOM. For the remaining period of the study, the animals 
were kept in stainless steel wire cages, two animals per cage. During the 
study the temperature was maintained at 22 2 1°C and relative humidity 
at 55 2 5%, air was changed 8-10 times/hr, and fluorescent light was on 
from 2100 to 0900. 
Experimental design. The animals were randomly assigned to the four 
experimental groups (14 animals per group) and after the predosing 
period A O M  (15 mgkg body wt) was administered subcutaneously once 
a week for 2 weeks. All animals were fed the group I basic diet during 
the predosing and dosing period and then allocated to their respective 
diets. 
Body weight and food consumption were measured weekly. The 
animals were sacrificed 18 weeks after the first AO.M-injection. 
Complete gross necropsy was performed on all the animals. The large 
intestine was cut longitudinally, rinsed in 0.9% NaCl solution, and 
divided into four pieces as described earlier (22). The colon segments 
were pinned on a cork slab and fixed in 4% neutral buffered 
formaldehyde. To visualize the ACF the colon segments were processed 
according to (22). The ACF were grouped into small (I-3.,crypts), 
medium (4-6 crypts), large (7-9 crypts) or extra large (21.0 crypts) foci. 
Colon tissue deviating from normal morphology at gross examination 
was embedded in paraffin, sectioned (4-6 urn) and stained’ with 
haematoxylin and eosin for microscopic examination. 
Statistics. One-way analysis of variance was used. to analyse body weight, 
weight gain and food consumption. A  test for normal distribution 
(Shapiro-Wilk) of ACF data was carried out on logarithmically 
transformed data. One-way analysis of variance on the logarithmically 
transformed data was used to determine the effect of diet on the ACF. 
Duncan’s multiple range test was used for pa&vise comparisons, A  
probability of 55% was considered significant.~All statistical calculations 
were carried out using proc GLM, SAS release 6.04. 
Results 
During the experimental period four animals from group III 
died accidentally from volvulus due to a torsion of the caecum 
about the ostia of the terminal ileum and proximal colon. No 
other treatment-related signs of clinical adverse effects on the 
animals in the different groups were observed during the 
experiment. However, the animals receiving the diet with 
potato starch as the only carbohydrate source were smaller, 
and showed a statistically significant reduction in body weight 
gain, compared with those in any other group after 5 weeks 
on the experimental diet (up to 28%). A concomitant 
decrease in food consumption was recorded in the potato 
starch fed animals, statistically significant compared to that of 
the other groups, from week 6 until week 1.1. The 
corresponding data for the relative food consumption in these 
animals showed a statistically significant increase from week 
10 and onwards. 
At necropsy a caecal enlargement was observed in group 
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Table I. Composition of diets. 
Group I II III IV 
Na-caseinate, %  20 20 20 20 
Carbohydrate mix a %  67 0 0 0 
Sucrose, %  0 67 0 0 
Potato starch, %  0 0 67 0 
Cornstarch, %  0 0 0 67 
Soya bean oil (with 
vitamins A, D, and E), %  4 4 4 4 
Mineral mixture, %  3.3 3.3 3.3 3.3 
Vitamins B  and K, choline 
chloride, inositol, and 
methionine, %  1.4 1.4 1.4 1.4 
Cellulose, %  4 4 4 4 
a: Carbohydrate mix: 45% cornstarch, 45% potato starch, 5% sucrose, 
5% dextrin. 
III. In addition, the livers from these animals appeared 
slightly pale and the lesions turned out to be diffuse fatty liver 
confined to the centrolobular zone. No signs of necrosis or 
fibrosis were seen. 
ACF. The total number and distribution of ACF are 
presented in Table II. In animals given potato starch a 
statistically significantly lower number of ACF in all 
categories but small was seen. With respect to small ACF, a 
statistically significant difference was seen between animals 
given potato starch and cornstarch. 
In addition, an effect of potato starch was reflected in the 
relatively fewer large and extra large ACF compared to the 
other groups (Table II). 
Compared to the standard diet sucrose and cornstarch did 
not show any effect on the development of ACF. 
Tumors. Macroscopically visible tumors were seen in groups I 
and II. No tumors were seen among animals given potato 
starch or cornstarch (Table III). 
Because of the low tumor incidence no statistical analysis 
was carried out. When assessed on individual animal findings, 
no correlation between number or crypt multiplicity of ACF 
and occurrence of tumors could be found (data not shown). 
Discussion 
The reduction in body weight gain in the group III animals 
receiving .67% potato starch compared to that of any of the 
other groups, including the group I receiving a carbohydrate 
mixture containing 30% potato starch, is considered to be 
consequence of the lower digestibility of the potato starch. 
Both the decrease in body weight gain and the concomitant 
increase in relative food consumption support previously 
reported data on potato starch (25-25). 
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Table II. Effect of different diets on the number and distribution ofACF according to the various number of cysts in colons of Wutar rats given AOM. 
No. of foci per colon a@J 
Wks Nd Group Small Medium I-axe X largee Total 
18 14 I 89.6k7.4xzy (52) 55.4*3.9x (32) 11.3*1.7x (7) 14.7~k2.3~ (9) 17O.9+11.6x 
18 14 II 122.Ok17.@ly (68) 41.4~6.1~ (23) 7.4~~1.2~ (4) 9.1k1.6x (5) 179.9-c24.2x 
18 10 III 85.0r18.2y (73) 26.6*6&y (23) 2.1kO.8y (2) 2.9-cl.lY (2) 116.6k24.w 
18 14 IV 115.6+1O.3x (61) 49.4k6.5x (26) 10.7~k2.7~ (6) 13.4*3.5x (7) 189.1&18.@ 
Statistical significance (One-way analysis of variance, P- values) 
0.1334 0.0036 0.0001 0.0001 0.0283 
a: All the values shown are mean 2 SE., values in parentheses are percentages of total. 
b: Small foci: l-3 cxypts; Medium foci: 4-6 crypts; Large foci: 7-9 crypts; X large foci: 10 or more crypts. 
c: Groups not sharing a common superscript differ significantly by Duncar& multiple range test (P I 0.05). 
d: N: effective number of rats. 
e: X large: extra large. 
The depression in body weight gain in the potato starch fed 
animals corresponds to that of rats on a moderately re&icted 
(50%) diet reported by Levin (29). 
Moderate dietary restriction versus ad libitum feeding,.@ a 
toxicological study caused in general qualitatively the same 
toxic response in different parameters, although sume 
quantitative differences were seen (30). Therefore it is 
considered that the imposed caloric restriction dit not impair 
the validity of the model used. 
All animals in group III showed a caecal enlargement 
which is regarded as a consequence of the microbi+ 
fermentation of the high resistant potato starch leading to 
production of a lot of volatile fatty acids in the large intestine. 
The caecal enlargement together with the anatomic 
disposition (the close proximity of the ileum and the colon 
exit in caecum) and the free mobility of the caecum is 
probably the cause of the four deaths observed in group III. 
The volatile fatty acids are readily absorbed and acetate 
and propionate are carried to the liver. Their actions here 
remain unclear (31), but an investigation by Yamamoto and 
Yamakava (32) has shown that 12 weeks’ administration of 
acetate to rats caused fatty degeneration in the liver. 
In rats fed potato starch a statistically significantly lower 
number of ACF in all categories but small were seen. 
Explanations of this could either be the lower daily caloric 
intake in the potato starch group or the substantial amounts 
of resistant starch in the potato starch used. 
Lasko and Bird (33) have shown that caloric restriction 
affects the number of AOM-induced ACF in rats. Compared 
to ad libitum fed rats, late intervention with caloric restriction 
for 12 weeks reduced the total number of ACF. Also, the 
number of colonic adenomas was reduced by caloric 
restriction. With respect to tumor development&he inhibiting 
effect of caloric restriction has been known for a long time. In 
a recent’ commentary Rogers and co-workers (34) summarize 
the mechanisms postulated for the reduction of tumorigenesis 
Table III. Incidence of colorectal tumors in rats fed four different 
carbohydrate sourcesa 
Group No. of Adenomas Adenocarcinoma Total no. of 
rats in situ tum0l-S 
I 14 3 (22) l(7) 4 (29) 
II ‘, 14 2 (14) 0 2 (14) 
III 10 0 0 0 
IV 14 0 0 0 
a: Values are expressed as no. of affected animals/total no. of animals, 
values in parentheses are percentages. 
by caloric restriction. Among these are: general reductidn in 
growth of all tissues, due to reduced growth-promoting blood 
hormor&; alteration of the metabolism of carcinogens; 
reduction in oxidative damage to DNA; and reduction of cell 
division, DNA synthesis, DNA adduct formation and 
alteration of Dr;rr\ repair. 
Accoiding to the method of Englyst et al (35), resistant 
starch constituted 55% of the potato starch used. The 
resistant starch may reach the large intestine and is here 
available for fermentation like dietary fibres. A few studies 
have shown that a high fibre diet reduced the number of ACF 
(21-23). Further, a case-control study by Marquart-Moulin et 
al (9) has revealed that a high intake of potatoes decreased 
the risk of cancer of the colon and rectum. 
Moreover, it has been shown that resistant starch forms 
more butyrate than most types of dietary fibre (4,5,31,36) 
tid that butyrate possesses anticarcinogenic properties 
(4,5,36,37). Studies have shown that human faecal 
suspensions were able to form high proportions of butyrate 
from potato starch (36,38). On the other hand, Mallett et al 
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(28) showed that, even though the total amount of volatile 
fatty acid in caecum was very high in rats fed potato starch, 
the main production was acetate. 
In the present study the relative number of ACF with high 
crypt multiplicity was lower in the animals fed potato starch. 
Some studies (19,39-41) have found the number of ACF with 
high crypt multiplicity to be a better predictor of tumor 
outcome than the total number of ACF. 
The cornstarch diet had no inhibitory effect on the 
formation of ACF. The reason might be that the cornstarch 
used only consists of 7% resistant starch according to the 
method of Englyst et al (35). Therefore only a minor amount 
of resistant starch reaches the large intestine for 
fermentation, e.g. it does not possess a substantial dietary 
fibre effect. 
It has been shown that refined sugar may be a risk factor 
for the development of cola-rectal cancer in humans (7-11) 
and enhances the development of ACF (22). In the present 
study sucrose did not cause any increase in the formation of 
ACF. 
Due to the short duration of the study only a few colon 
tumors were seen, but it is noticeable that no tumors were 
observed in animals given the high-starch diets. This 
observation supports the suggestion by Cassidy et al (6) and 
Marquart-Moulin et al (9) that starch plays an important role 
in protection against cola-rectal cancer in humans. 
This study revealed a significant inhibitory effect of potato 
starch on the development of ACF. Whether this effect of the 
potato starch is an effect of the starchperse or an effect of the 
caloric restriction created has to be further investigated. 
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PAPERIV 
The ability of two cooked food mutagens 
to induce aberrant crypt foci in mice 
E Kristiansen, 0 -Meyer, I Thorup 
‘Recci~ed 24 September !995; accepted 25 February 1996) 
The aberrant crypt foci assay has been used extensively to study different compounds for chemopreventive 
action, but almost all investigations have used initiators not normally found in the diet. In the present study 
two food-borne initiators, 2-amino-3-methyl-imidazo[4,5Jlquinoline (IQ) and 2-amino-1-methyl-6-phenyl- 
imidazo[4,5b]pyridine (PhIP) were used. To simulate the human exposure further, we chose a feeding 
regimen with continuous low IQ- and PhIP-doses. Throughout the study female mice were given diets with 
or without 0.03% IQ or 0.03% PhIP. Two additional groups were given azoxymethane (AOM) (5 mg/kg 
body weight) and 1,2-dimethylhydrazine dihydrochloride (DMH-2HCl) (20 mg/kg body weight), respectively, 
one dose a week for two weeks. Animals were killed after four and 10 weeks. After four weeks only the 
mice dosed with IQ and PhIP had aberrant crypt foci. A much higher number of aberrant crypt foci 
were found in the IQ mice (31.8 -c 5.2) than in the PhIP mice (0.5 -c 0.3). After 10 weeks aberrant crypt 
foci were found in all dosed groups. The IQ mice had significantly more (P s 0.001) small and total aber- 
rant crypt foci than the other groups. AOM and DMH induced a higher percentage of medium or large 
sized aberrant crypt foci than PhIP or IQ. The interpretation of the aberrant crypt foci as precursor lesions 
for colon cancer in the PhIP and IQ mice is difficult because PhIP and IQ have not been reported to be 
colonic carcinogens. If cooked food mutagens such as IQ or PhIP are to be used as initiators in the aber- 
rant crypt foci test, the use of rats may be preferable. 
Key words: Aberrant crypt foci, initiators, IQ, mice, PhIP. 
Introduction 
With increasing demands for the testing of potential in the diet. The two colon carcinogens 1,2-dimethyl- 
anticarcinogenic compounds in foods there is a need hydrazine dihydrochloride (DMH) or azoxymethane 
for models which produce test results within a few (AOM) have mostly been used. If food-borne initia- 
months. The aberrant crypt foci assay is a short-term tors in the human diet could be used in the aber- 
model and evidence supports the hypothesis that the rant crypt foci assay, this test could be a very useful 
development of aberrant crypt foci in laboratory model to screen for the effects of proposed dietary 
animals and people is indicative of a potential anticarcinogens on colon carcinogenesis. Thus, 
carcinogenic effect in the large bowel (Bird et al, we decided to test the aberrant crypt foci assay 
1989; Pretlow et al, 1991; Roncucci et al, 1991a,b). using two heterocyclic amines formed during heat- 
The assay has been used by several investigators to ing of protein-containing foods, 2-amino-3-methyl- 
study chemicals and dietary components for chemo- imidazo[4,5-flquinoline (IQ) and 2-amino-l-methyl- 
preventive action (reviewed by Bird, 1995a), but the Gphenyl-imidazo[4,5-blpyridine (PhIP). To simulate 
published data almost exclusively deal with study further likely human exposure, we chose a feeding 
designs where the initiators are not normally found regimen with continuous low doses of IQ and PhIP. 
Institute of Toxicology, National Food Agency, 19 Morkhoj Bygade, DK-2860 Soborg, Denmark. Correspondence to: E Kristiansen. 
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Both IQ and PhIP are mutagenic and carcinogenic 
in laboratory animals (Eisenbrand and Tang, 1993). 
Compounds like IQ and PhIP, and also probably 
many of the potentially anticarcinogenic compounds, 
are in short supply and often very expensive. Hence, 
the use of mice would obviously be more beneficial 
than rats. The only reported study on IQ- and PhIP- 
induced aberrant crypt foci in mice is a three-week 
study by Tudek et al (1989) in which a few aberrant 
crypt foci were observed after administration of two 
doses of IQ (total 400 mg/kg body weight) and PhIP 
(total 150 mg/kg body weight) over a period of three 
weeks. The aim of the present study was to evaluate 
the use of low doses of IQ or PhIP administered over 
4-10 weeks to mice in the aberrant crypt foci assay 
and compare these with DMH and AQM. 
Methods 
Animals 
Seventy four-week-old female mice C57BL/6.T, 
specified as pathogen-free, were purchased from 
Bomholtg6rd Breeding and Research Centre Ltd, 
Denmark. The mice were randomly allocated by 
weight into the different groups (Table 1) and were 
individually marked by ear tags and tail marks. 
Diets 
The animals were offered a pellet diet of Altromin 
1314. Altromin 1314 pellets with 0.03% IQ (group 
II) or 0.03% PhIP (group III); respectively, were 
prepared by Altromin GmbH u. Co KG, Lage, 
Lippe, Germany (Table 1). Analyses of IQ and PhIP 
in the two batches of prepared pellets were in accor- 
dance with the amount added. 
Table l. Allocation of mice into treatment groups 
Group Diet Initiation at No of 
2 weeks AUiUlaLs* 
I 
II 
III 
Iv 
V 
AItromirl1314 0 14 
Akromin 1314 0 14 
with 0.03% PhIP 
Ahromin 1314 0 14 
with 0.03% IQ 
AItromin 1314 AOM 14 
5 mgflrs 
bwlweek 
Altromin 1314 ?m 14 
myQ3 
bwlweek 
* 4 animals in 4 weeks, and 10 animals in 10 weeks. 
The animals in groups IV and V were offered 
Altromin 1314 and dosed intraperitoneally (10 ml/kg 
body weight) with AOM (5 mg/kg body weight) and 
DMH-2HCl (20 mgkg body weight), respectively, 
once a week for two weeks. 
Chemicals 
1,2-Dimethylhydrazine dihydrochloride (DMH- 
2HCl) and azoxymethane (AOM) were obtained 
from Sigma Chemical Co (St Louis, MO, USA). 2- 
Amino-3-methyl-imidazo[4,5-flquinoline (IQ) and 
2-amino-l-methyl-6-phenyl-imidazo[4,5-blpyridine 
(PhIP) were a generous gift from Dr Snorri S 
Thorgeirsson, National Cancer Institute, Bethesda, 
MD, USA. 
Housing 
The animals were kept in polycarbonate cages on 
beech bedding (Spanvall Red Special, Spanvall 
Jerslev, Demnark) with two females in each cage. 
The groups dosed with AOM and DMH-2HCl were 
kept in a flexible film isolator (Isotec 12134, Olac 
Inc, Oxford, UK) during the week before dosing 
started, during the 2 weeks of the dosing period, and 
for 2 weeks after termination of the dosing. During 
the study, the temperature was maintained at 22 & 
1°C and relative humidity at 55 f 5%, air was 
changed S-10 times/h, and fluorescent light was kept 
on from 2100 to 0900 h. 
Experimental design 
Body weight and food consumption were measured 
weekly. Interim sacrifices were performed 4 weeks 
after the first dose (4 animals/group) and the re- 
maining animals were killed after 10 weeks (10 
animals/group). Complete gross necropsy was per- 
formed on all animals, and the large intestine was 
examined microscopically. Before bation, the large 
intestine was cut longitudinally and rinsed in 0.9% 
NaCl solution. The colon was then pinned on a cork 
slab and tied in 4% neutral buffered formaldehyde. 
After fixation, Giemsa stain (6 ml of concentrate in 
50 ml of phosphate-buffered saline (PBS), pH 7.1, 
for 15 min) was used to visualize the aberrant crypt 
foci and excess stain was rinsed off with PBS. The 
tissue was placed luminal side up in a Petri dish with 
enough PBS to cover the tissue. The total number 
of aberrant crypt foci and the number of aberrant 
crypts per focus were recorded using a stereo- 
microscope at x 40 magnification. 
The aberrant crypts were distinguished by their 
increased size, thicker and deeply stained epithelial 
lining, and increased pericryptal zone compared with 
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normal crypts (McLellan and Bird, 1991). An aber- 
rant crypt focus may consist of one to several crypts, 
and the aberrant crypt foci were grouped into 
small (l-3 crypts), medium (4-6 crypts) or large 
(7-9 crypts). Colon tissue deviating from normal 
morphology at gross examination was embedded 
in paraffin wax, sectioned (4-6 pm), and stained 
with haematoxylin and eosin for microscopic exami- 
nation. 
Statistics 
One-way analysis of variance was used to analyse 
body weight, weight gain, and food consumption. A 
test for normal distribution (Shapiro-Wilk) of aber- 
rant crypt foci data was carried out, and one-way 
analysis of variance was used to determine the effect 
of treatment on the development of aberrant crypt 
foci. Duncan’s multiple range test was used for pair- 
wise comparisons. A probability of G 5% was 
considered significant. All statistical calculations 
were carried out using SAS release 6.04. 
Results 
Seven mice died of peritonitis after the Grst dose 
with DMH due to an increase in pH in the DMH 
solution. This was corrected before the second injec- 
tion. Because of these accidental deaths no DMH 
mice were killed after 4 weeks. 
Body weight and food consumption 
Apart from the observed accidental deaths in the 
DMH animals, no treatment-related signs of adverse 
effects in the clinical appearance of the animals were 
observed during the experiment. 
The data revealed an initially significant relative 
Cooked food mutagens and aberrant crypt foci 
decrease in body weight in the PhIP, DMH, and IQ 
anidals, the IQ animals having the lowest decrease. 
The average body weight in the PhIP and IQ animals 
remained low compared with that of the controls 
(from 5-14% reduction) during the dosing period. 
However, no consistently significant changes in body 
weight gain were recorded from week 1 of the dosing 
period onwards. 
The figures for food intake showed an initially 
sign$cant decrease in the DMH-dosed animals, 
followed by a relative increase over the next three 
weeks. The data for the animals fed either PhIP or 
IQ showed that there was a significant decrease in 
food consumption from the initiation of the dosing 
period onwards. 
Aberrant crypt foci 
Aberrant crypt foci were not observed in the colon 
of control mice (group I). In animals killed after four 
weeks only the mice dosed with IQ and PhIP showed 
aberrant crypt foci. A much higher number of aber- 
rant crypt foci were found in the IQ mice (31.8 i 
5.2) than in the PhIP mice (0.5 f 0.3) (Table 2). Ten 
weeks after the first dose, aberrant crypt foci were 
found in all dosed groups. The mice dosed with IQ 
had both significantly more small (P < 0.001) and 
total aberrant crypt foci (P G 0.001) than the other 
dosed groups. In the AOM- and DMH-induced mice 
a substantially higher percentage of medium or 
large-sized aberrant crypt foci were seen compared 
with the PhIP and IQ-induced mice (Table 2). 
In the IQ-fed animals the aberrant crypts were 
seen primarily in the caecal part of the colon, 
whereas the aberrant crypt foci in the DMH animals 
were seen primarily in the mid-colon. The aber- 
rant crypt foci induced by PhIP and AOM were 
Table 2. Influence of different diets on number and distribution of ACF in mice according to number 
of crypts in focus 
ACFkolon (Mean (SE))( %) 
Weeks No of rats Group Small* Medium Large Total 
4 4 II 0.5 (0.3) (100) 0.0 (0.0) (0) 0.0 (0.0) (0) 0.5 (0.3) 
4 III 31.8 (5.2) (99) 0.3 (0.3) (1) 0.0 (0.0) (0) 32.0 (5.4) 
4 Iv 0.0 (0.0) (0) 0.0 (0.0) (0) 0.0 (0.0) (0) 0.0 (0.0) 
10 10 II 3.7 (1.0) (loo) 0.0 (0.0) (0) 0.0 (0.0) (0) 3.7 (1.0) 
10 III 71.2 (4.2) (99)Y 0.2 (0.1) (1) 0.0 (0.0) (0) 71.4 (4.1)Y 
10 Iv 1.6 (0.9) (SS), 0.1 (0.1) (6) 0.1 (0.1) (6) 1.8 (1.0) 
10 V 7.9 (2.4) (90) 0.9 (0.3) (10) 0.0 (0.0) (0) 8.7 (2.7) 
* Small foci, l-3 crypts; medium foci, 4-6 crypts; large foci, 7-9 crypts. 
%Y Groups not sharing a common superscript (x,y) differ signikantly according to Dmxan’s multiple range test 
(P c 0.05). 
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distributed more randomly in the colon. No tumours 
were detected in any of the animals in groups II-V. 
Discussion 
The animals tolerated the dietary exposure to PhIP 
and IQ. The relative decrease in body weight in the 
PhIP and IQ animals supports data from studies in 
which mice were fed dietary levels of 0.04% and 
0.03 % PhIP and IQ, respectively (Ohgaki et al, 1984, 
Esumi et al, 1989). As to the lower food intake in 
the PhIP animals, a similar effect was observed in 
another study at the Institute of Toxicology in which 
mice were fed a diet of PhIP (Mortensen, 1995, 
personal communication). Whether the cause of the 
lowered food intake is a consequence of a specific 
toxicological effect of PhIP and IQ, or reduced 
palatability of the test diets, has not been estab- 
lished. 
It has been widely reported that aberrant crypt 
foci are markers for the development of colon cancer 
(Bird, 1995a). Aberrant crypt foci have been 
suggested to be biologically heterogeneous lesions 
where only a subpopulation persists and develops 
into cancer (Bird, 1995b). 
The interpretation of the aberrant crypt foci as 
precursor lesions is difficult because neither of these 
chemicals has been reported as being carcinogenic 
in the colons of mice (Ohgaki et al, 1984; Esumi 
et al, 1989). This suggests that the aberrant crypt foci 
induced by these two chemicals do not represent 
early stage colon cancer. 
One explanation might be that PhIP and IQ are 
only weakly carcinogenic to the colon compared 
with other organs, and therefore tumours arise in 
the liver, forestomach and lung in the case of IQ 
(Ohgaki et al, 1984) and in the lymphoid tissue in 
the case of PhIP (Esumi et al, 1989) long before they 
arise in the colon. Whether PhIP induces tumours 
in other organs in mice is not yet known, as only 
the data on lymphomas have been published, and a 
thorough histological examination of this carcino- 
genicity study in mice (Esumi et al, 1989) still 
remains to be reported. Importantly, the suscepti- 
bility to colon carcinogens in mice is dependent on 
strain (Diwan and Blackman, 1980; Deschner et al, 
1983), and many of the carcinogenic@ studies on 
heterocyclic amines (including IQ and PhIP) have 
been performed on the hybrid mouse CDF, 
[(BALB/cAnN x DBA/2N)F,] in which the suscep- 
tibility might not be very strong. 
Another explanation for the lack of concordance 
might be that the aberrant crypt foci induced in the 
caecal part (the herringbone structure) of the colon 
- the case with IQ - have no potential to develop 
into cancer. This theory is supported by the data 
from Tudek et al (1989) where aberrant crypts 
induced by IQ and benzo[a]pyrene, both of which 
are not carcinogenic to mouse colon, were more 
common in the caecal end of the colon. 
The well known mice colon carcinogens AOM 
and DMH induced a substantially higher percentage 
of medium- or large-sized aberrant crypt foci than 
either PhIP or IQ (Table 2), supporting the concept 
that aberrant crypt foci with a higher crypt multi- 
plicity represent increasing potential to develop into 
cancer (Zhang et al, 1992; Magnuson et al, 1993). 
In the AOM group no aberrant crypt foci were 
detected after 4 weeks. This was unexpected, as 
McLellan and Bird (1988a,b) in two studies with the 
same species and sex of mice and only a single dose 
of 15 mg/kg body weight induced 2.5 t 0.4 and 2.6 
t 0.93 aberrant crypt foci per colon, respectively, 
after 4 weeks. 
Even though we used a species of mice which is 
moderately resistant to DMH (Deschner et al, 1983), 
our results with DMH after 10 weeks (8.7 + 2.7 aber- 
rant crypt foci/colon) are also relatively low. Lam 
and Zhang (1991) who treated CFl mice (a sensi- 
tive strain) twice orally with DMH (20 mg/kg body 
weight), found 13-17 aberrant crypt foci per animal 
in three different experiments 21 days after the last 
treatment. The distribution of the aberrant crypts 
after DMH induction agrees with the data from 
Tudek et al (1989). 
Even though abundant published findings are 
available on aberrant crypt foci as an early marker 
for colon cancer, some investigations have failed to 
show a correlation between aberrant crypt foci and 
colon cancer (Hardman et al, 1991; Carter et al, 1994; 
Thor-up et al, 1994; Kristiansen et al, 1995). In the 
study by Carter et a2 (1994) using DMH-induced 
mice, the authors proposed that aberrant crypt foci 
have little, if any, malignant potential in mice. 
Likewise, Steele and Kelloff (1993) testing 42 
chemopreventive agents, found that all of the false 
positive data (positive crypt/negative tumour) were 
derived from mouse tumour studies and the authors 
indicated that some species differences may exist. 
In light of these observations, our conclusion is 
that if cooked food mutagens. such as IQ or PhIP 
are to be used as initiators in the aberrant crypt foci 
test, the use of rats may be a better choice because: 
(1) in carcinogenicity studies with rats, the colon is 
the target organ for both IQ (Takayama et al, 1984) 
and PhIP (Ito et al, 1991) whereas the target organs 
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in mice have been liver, forestomach and lung for 
IQ (Ohgaki et al, 1984), and the lymphoid tissue for 
PhIP (Esumi et al, 1989); (2) in rats induction of 
aberrant crypt foci in the colon has been demon- 
strated after both IQ &d PhIP administration 
(Tudek et al, 1989; Takahashi et al, 1991; Hasegawa 
et al, 1993); (3) the distribution of aberrant crypt foci 
in the colon of IQ or PhTP-dosed rats is comparable 
with that in rats given AOM or DMH, and corre- 
lates well with the distribution of tumours (Tudek 
et al, 1989; Hasegawa et al, 1993). 
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Refined carbohydrate enhancement of aberrant crypt foci (ACF) in rat 
colon induced by the food-borne carcinogen 2-amino-3- 
methyl-imidazo{4,5fiquinoline (IQ) 
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Abstract 
The aberrant crypt foci (ACF) bioassay has been used extensively to study the early effects of different dietary compo- 
nents on the colonic mucosa of laboratory rodents. ACF are proposed to represent preneoplastic lesions of colon cancer. 
Compared to the normally used initiators 1,2-dimethylhydrazine dihydrochloride (DMH) and azoxymethane (AOM), the use 
of a diet-related colon cancer initiator, such as the heterocyclic amine 2-amino-3-methyl-imidazo[4,5-flquinoline (IQ) formed 
during meat cooking, would probably give a more relevant insight into diet-related colon carcinogenesis. In the present study 
it is shown that a feeding regimen with continuous low IQ doses (0.03% in the diet) throughout a study period of 10 weeks 
has a significant effect on the induction of ACF in the colon of male F344 rats. In addition, the study illustrates that the inci- 
dence of the IQ-induced ACF can be modulated by the amount of refined carbohydrates in the diet. Rats given a high su- 
crose/dextrin diet showed a significantly higher number of ACF compared to rats given a diet high in starches. The effect on 
tumor outcome will await the termination of a ongoing parallel study. 
Keywords: Aberrant crypt foci; 2-Amino-3-methyl-imidazo[4,5-flquinoline (IQ); Refined carbohydrates; Colon; Rats 
1. Introduction 
The aberrant crypt foci (ACF) assay has been used 
extensively to study the early effects of different die- 
tary components on the colonic mucosa of laboratory 
rats and mice [l]. The induction of ACF is believed to 
be indicative of a potential carcinogenic effect in the 
large bowel (2-51. In most of the published animal 
* Corresponding author. Tel.: +45 31 696600; fax: +45 39 
660100; e-mail: ek@lst.min.dk 
experiments studying dietary components the two 
colon carcinogens, 1,2-dimethylhydrazine dibydro- 
chloride (DMH) or azoxymethane (AOM), not nor- 
mally found in the diet, have been used as initiators. If 
food-borne initiators in the human diet, such as the 
heterocyclic at-nines, formed during cooking of fish 
and meat [6] could be used in the ACF-assay, this test 
would be even more useful as a model in screening for 
dietary modulation of colon carcinogenesis. Recently 
we investigated the use of the two food-borne rodent 
carcinogens, 2-amino-3-met.hyl-imidazo[4,5-~quino- 
line (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4-,5- 
. 
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b]pyrid$e (PhlP) as initiators in the ACF assay with 
mice fed continuous low doses of IQ or PhIP. Based 
on the observations in the study we came to the con- 
clusion that if cooked food mutagens such as IQ or 
PhIP were to be used as initiators in the ACF test, the 
preferred rodent to use would be rat [7]. 
The present paper describes the effect of IQ as ini- 
tiator in the ACF assay using male Fischer 344 rats. To 
test the possible dietary modulation on IQ-induced 
ACF, groups of rats were offered a diet high in refined 
carbohydrates, which is known to have a pronounced 
effect on ACF development [8-101. 
2. Materials and methods 
2.1. Animals and housing 
Forty 3-week-old male rats (Mol:Fischer 344) were 
obtained from M$lleg&d Breeding Center (Ll. Skens- 
ved, Denmark). The animals were kept in stainless 
steel wire cages, two animals per cage. During the 
study the temperature was maintained at 22 & 1°C and 
relative humidity at 55 +: 5%, air was changed 8-10 
tin&h, and fluorescent light was on from 2100 to 
0900 h. 
Table 1 
Composition of diets 
Ingredients Group 
I II III Iv 
Na-caseinate 20 20 20 20 
Carbohydrate mixa 67.3 0 67.3 0 
Carbohydrate mixb 0 67.3 0 67.3 
Soya bean oil (with 4 4 4 4 
vitamins A, D, and E) 
Mineral mixture 3.3 3.3 3.3 3.3 
Vitamins B and K, 1.4 1.4 1.4 1.4 
choline chloride, 
inositol and methionine 
Cellulose 4 4 4 4 
IQ 0 0 0.03 0.03 
All data arc percentages. 
acarbohydrate mix: 45% cornstarch, 45% potato starch, 5% SU- 
crose, 5% dextrin. 
bCdohydrate mix: 5% cornstarch, 5% potato starch, 45% su- 
crose, 45% dextrin. 
2.2. Chemical 
IQ was purchased from Toronto Research Chemi- 
cals (Ontario, Canada). 
2.3. Diets 
The animals were offered a pellet diet without or 
with 0.03% IQ, prepared by Altromin GmbH u. Co. 
KG, Lage, Lippe, Germany. The composition of the 
different diets is given in Table 1. Animals in group I 
received the basic semisynthetic diet based on the for- 
mula given in [ 111. In the group II diet the carbohy- 
drate pool was reversed from 90% starches and 10% 
dexttin/sucrose to 10% and 90%, respectively. Groups 
III and IV received diets similar to groups I and II 
supplemented with 0.03% IQ. Analyses of IQ in the 
batch of pellets prepared were in accordance with the 
amount added. 
2.4. Experimental design 
The animals were randomly assigned to the four 
experimental groups (ten animals per group). The ani- 
mals were fed the group I basic diet in the l-week ac- 
climatization period and then allocated to their respec- 
tive diets (Table 1). Body weight and food consump- 
tion were measured weekly. The animals were sacri- 
ficed after 10 weeks on the test diets. Complete gross 
necropsy was performed on all the animals. The large 
intestine was cut longitudinally, rinsed in 0.9% NaCl 
solution, and divided into two pieces. The two colon 
segments were pinned on a cork slab and fixed at 4°C 
in 4% neutral buffered formaldehyde for 20 h. To 
visualize the ACF the colon segments were processed 
according to [8]. ACF were enumerated and grouped 
into small (l-3 crypts) and medium (4-6 crypts) foci. 
2.5. Statistical analysis 
The parametric one-way analysis of variance 
(General Linear Models Procedure) was used to ana- 
lyze body weight, weight gain, and food consumption 
and Duncan’s multiple range test was used for pairwise 
comparisons. To analyze number and distribution of 
ACF between groups the non-parametric Wilcoxon 
two-sample rank-sum test (NPARIWAY Procedure) 
was used. A probability of S5% was considered sig- 
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Table 2 
Influence of different diets on number of ACF in rats and 
distribution of ACF according to number of crypts in focus 
Group ACFlcolon 
Smalla Mediumb Total 
I OC OC OC 
II OC OC OC 
III 5.3 + 0.9 (88)d 0.7 + 0.4 (12)d 6.0 + l.Od 
Iv 10.3 + 1.9 (97)c 0.3 + 0.2 (3)“d 10.6 -c 1.9e 
Values are means f SE; numbers in parentheses represent percent- 
age of total; effective number of rats = 10 for each group; number 
of weeks on each diet = 10. 
aSmall foci, l-3 crypts. 
bMedium foci, 4-6 crypts. 
C,d,eGroups not sharing a common superscript differ significantly 
when tested pairwise in Wilcoxon rank-sum test (P 5 0.05). 
nificant. All statistical calculations were carried out 
according to SAS release 6.11. 
3. Results 
During the experiment, no treatment-related signs 
of adverse effect in clinical appearance of the animals 
were observed. A  slight but statistically significant 
decrease in body weight was seen in the IQ-dosed 
animals from the sixth week of dosing irrespective the 
composition of the diet. A  concomitant decrease in 
food consumption was recorded in the IQ-fed animals, 
statistically significant compared to either of the other 
groups, from the first week of dosing. 
The total number and distribution of ACF are pre- 
sented in Table 2. For the categories small and total the 
amount of IQ-induced ACF reached the level of sig- 
nificance compared to their respective controls. W ith 
respect to the category medium, significance was 
found between groups I and III. Further, it was seen 
that the refined carbohydrate diet (group IV) induced a 
statistically significantly higher number of small and 
total ACF compared to standard diet (group III). 
4. Discussion 
The animals adapted well to the dietary exposure to 
IQ, and no influence of the change in dietary carbohy- 
drate pool was recorded in clinical appearance, body 
weights or food consumption. The slight relative de- 
crease in body weight in the IQ-fed animals supports 
the data from Takayama et al. [ 121. 
The present study shows that a feeding regimen 
with continuous low IQ doses throughout the study 
period has a significant effect on the induction of the 
number of small ACF as well as the total number of 
ACF in rat colon. As far as we know this is the first 
ACF study using this protocol with low continuous IQ 
doses, which is more similar to human exposure to 
food-borne heterocyclic amines. Three other ACF 
studies have been conducted with IQ, and all have used 
few, high doses of IQ. Tudek et al. [ 13 3 treated female 
SD rats with either 100 or 200 mg/kg IQ twice by gav- 
age, 4 days apart, and scored after 3 weeks, and 
Tachino et al. [14] and Liew et al. [ 151 used a dosing 
scheme with oral gavage of 130 or 100 mg/lcg IQ, re- 
spectively, on alternating days for 2 weeks and scoring 
after 12 or 13 weeks, respectively. 
Moreover, the study illustrates that the incidence of 
IQ-mduced ACF can be affected by dietary modulators 
such as refined carbohydrates. IQ-dosed animals given 
a diet high in refined carbohydrates had a statistically 
significantly higher number of small and total ACF 
compared to IQ-dosed animals given standard diet. 
The increase in total number was approximately two- 
fold. The difference was not reflected in the medium- 
size ACF. The modulation of ACF by refined carbo- 
hydrates is seemingly inducer-dependent. In a recent 
study [8] with W istar rats, where DMH was used as 
both initiator and promoter (20 mg/kg weekly for 
20 weeks), the same high refined carbohydrate diet 
increased the total number of ACF 2.7-fold after 
10 weeks feeding. The highest increase was seen in 
number of small ACF, but the number of medium, 
large and extra-large ACF were increased as well. In 
contrast, when AOM was used solely as initiator 
(15 mg/kg weekly for 2 weeks) no statistically signifi- 
cant effect on the number of ACF after 10 weeks 
feeding on a high sucrose diet was seen [ 161. 
The modulating effect of diets high in refined car- 
bohydrates on development of ACF has been reported 
by others. In DMH-induced rats Cademi at al. [9] 
found that a high-sucrose diet caused a significant in- 
crease in the percentage of large ACF (3-6 crypts) and 
a reduction in percentage of small ACF (l-2 crypts) 
compared with a high-starch diet. Stamp et al. [lo] 
have compared the effect of the refined sugars sucrose, 
glucose, and fructose on ACF in AOM-induced mice. 
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The results showed that oral gavage of sucrose and 
fructose led to a significant increase in number of ACF 
while glucose did not. In addition, case-control studies 
have indicated that refined sugar may be a risk factor 
for human colorectal cancer [ 17-2 11. 
Our results concerning refined sugars have shown 
that when studying colon cancer modulating test sub- 
stances it may be important to investigate more than 
just one class of colon cancer initiators. This is also 
illustrated by the two compounds chlorophyllin (CHL) 
and indole-3-carbinol (13C). CHL is an inhibitor of 
PhIP-induced ACF [22] and IQ-induced colon cancer 
[23]. However, CHL neither decreases nor increases 
AOM-induced ACF [24], and when DMH is used as 
initiator CHL acts as a promoter of colon cancer [25]. 
Similarly, 13C is a inhibitor of PhIP-induced ACF [22], 
but enhances DMH-induced colon carcinogenesis 1261. 
So, in addition to being of relevance to the human 
situation, the introduction of heterocyclic amines in the 
ACF assay in that way may also provide new informa- 
tion about the mechanisms behind colon cancer 
modulation. 
The mechanism behind IQ induction of ACF in the 
colon is not known. The major site of activation of IQ 
to active metabolites is the liver. IQ is activated to a 
mutagenic metabolite by microsomes [27] and is a 
colon, small intestine, liver, Zymbal gland, skin, and 
clitoral gland carcinogen in rats [ 121. Unchanged IQ is 
present in the gut when given perorally to rats and here 
it has been shown to be converted to a direct-acting 
mutagen 7-hydroxy-2-amino-3,6-dihydro-3-methyl- 
7H-imidazo[4,5-Aquinoline-7-one (7-OHIQ) by the 
gut bacteria. 7-OHIQ has also been detected in feces of 
humans ingesting a high level of fried meat. The bac- 
terial metabolism of .IQ, which is influenced by the 
composition of the diet, has been proposed to play a 
role in the induction of DNA damage in the colonic 
mucosa [28]. However, 7-OHIQ was not carcinogenic 
in rats in a study by Weisburger et al. [29], and they 
concluded that it is not likely that the bacterial me- 
tabolite of IQ, 7-OHIQ, accounts for the colon cancer 
risk in individuals consuming IQ and related hetero- 
cyclic amines. More likely, the carcinogenic effect 
may depend on the formation of N-hydroxy-IQ, or N- 
hydroxy-N-acetyl-IQ activated locally by enzymes 
such as N,O-acetyltransferase [29]. Oral administration 
of IQ results in formation of colonic mucosa-specific 
formation of DNA adducts in male F344 rats. The 
formation has been shown to be caused most likely by 
the absorption of carcinogen through the lumen [30]. 
In conclusion, the present study showed that a 
feeding regimen with continuous low IQ doses 
throughout the study period has a significant effect on 
the induction of ACF in rat colon and that a diet high 
in refined carbohydrates enhances the IQ-induced 
ACF. The effect on tumor outcome will await the ter- 
mination of an ongoing parallel study. 
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in the development of colon cancer in mice 
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Abstract 
Aberrant crypt foci (ACF) have recently heen identified as early putative preneoplastic lesions which appear in the colons of 
experimental animals treated with colon carcinogens. In a recent study the two heterocyclic amines, 2-amino-3-methyl- 
imidazo[4,5-flquinoline (IQ) and 2-amino-l-methyl-6-phenyl-imidazo[4,M]pyridine (PhIP) were shown to be able to induce 
ACF in the colon of mice after, respectively, 4 and 10 weeks of exposure. In spite of the induction of ACF in colon of mice, IQ 
and PhIP have not been found to have colon as target organ in carcinogenicity studies. Therefore, one may question that ACF 
induced by IQ and PhIP in mice represent early stages of colon cancer. In order to investigate the possible role of PhIP- and 
IQ-induced aberrant crypt foci in the development of colon cancer in mice, colons from mice participating in other IQ- and 
PhIP-studies of much longer duration were analyzed for ACF. The results of these studies showed that the mimber of ACF 
increased statistically significantly over time, and that the small ACF were predominant (95-100%) at all time-points. In 
conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in 
mice colon after IQ- or PhJP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that 
only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome. 
Keywords: Aberrant crypt foci; Heterocyclic amines; 2-Amino-3-methyl-imidazo[4,5$Jquinoline (IQ); 2-Amiio-l-methyld- 
phenyl-imidazo[4,5-blpyridine (PhIP); Mice 
1. Introduction 
Food-borne heterocyclic amines, such as 2-amino- 
3-methyl-imidazo[4,5-flquinoline (IQ) and 2-amino- 
l-methyl-6-phenyl-imidazo[4,Sb]pyridine (Phm, 
are formed during cooking of meat and fish. They 
* Corresponding author. Tel.: +45 3 1 696600, ext. 4146; fax: +45 
39 660100; e-mail: ek@lst.min.dk 
are mutagenic to bacteria and cultured mammalian 
cells and are carcinogenic in laboratory animals [l]. 
Colon cancer is believed to develop in a step wise 
manner in which genetic alterations accumulate and 
eventually lead to overt cancer [2]. Very early (2-4 
weeks) after treatment with colon carcinogens, dis- 
tinct morphological lesions known as aberrant crypt 
foci (ACF) can be observed in unembedded colon 
tissue stained with Giemsa or methylene blue. The 
03&l-3835/96/$12.00 Copyright 0 1996 Elsevier Science Ireland Ltd. All rights reserved 
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induction of ACF is believed to be one of the early 
steps in colon carcinogenesis and to be indicative of a 
potential carcinogenic effect in the large bowel [3-61. 
High frequencies of ACF have been observed in the 
colonic mucosa of rats and mice treated with colon 
carcinogens and in humans with increased risk of 
developing colon cancer [7]. 
In a recent study the two heterocyclic arnines, IQ 
and PhIP, have been tested for their ability to induce 
ACF in the colon of mice after 4 or 10 weeks of 
exposure [8]. The two model colon carcinogens 1,2- 
dimethylhydrazine (DMH) and azoxymethane 
(AOM) were also tested. ACF were induced by alI 
test substances. IQ induced significantly more small 
ACF than the other groups, while AOM and DMH 
induced a higher percentage of ACF 2 4 AC/Foci 
compared to the PhIP- and IQ-treated mice. 
Two other studies on IQ- and PhIP-induced ACF in 
mice have been reported [9,10]. Tudek et al. [9] 
observed a few ACF in a 3-week study after admin- 
istration of two doses, 4 days apart, of IQ (total dose 
400 mg/kg body weight) and PhIP (total dose 150 mgl 
kg body weight) to CFl mice. In a study using MINI 
+ mice, Steffensen et al. [lo] found that PhIP given in 
four weekly i.p injections of 50 mg/kg body weight 
increased the number of both ACF and tumours in 
colons of the MINI + mice [lo]. 
In spite of the induction of ACF in colon of mice, 
IQ and PhIP have not been found to have colon as 
target organ in carcinogenicity studies. PhIP is a 
mouse lymphomagen, while IQ induces liver, lung 
and forestomach tumors in mice [ 11,121. Therefore, 
one may question that ACF induced by IQ and PhIP in 
mice represent early stages of colon cancer. 
To shed further light on the possible role of PhIP- 
and IQ-induced aberrant crypt foci in the development 
of colon cancer in mice, colons from wild-type mice 
participating in a series of other IQ- and PhIP-studies 
of longer duration were analyzed for ACF (Table 1). 
Table 1 
Experimental conditions for the studies included in the present paper 
The aim of these studies was not to study ACF for- 
mation, and hence they were not designed as regular 
ACF-studies. However, due to the long duration of the 
studies, an investigation of the colons for ACF forma- 
tion possibly could give some information about the 
fate of the ACF detected after 4 and 10 weeks treat- 
ment. 
The present paper summarizes the results obtained 
from scoring ACF in colons from female mice in three 
studies where IQ or PhIP were used as.. initiating 
agents [8,13,14]. 
2. Materials and methods 
The experimental conditions are given in Table 1. 
The animals received pelleted diets Altromin 1314 
with 0, 0.03% IQ, or 0.03% PhIP added (Altromin 
GmbH u., Co KG, Lage, Germany). The treatment 
period and duration of the studies appear from Table 
1. After sacrifice the large intestine was examined 
microscopically. Before fixation, the large intestine 
was cut longitudinally and rinsed in 0.9% NaCl solu- 
tion. The colon was then pinned on a cork slab and 
fixed in 4% neutral buffered formaldehyde. To visua- 
lize the ACF the colon segments were processed 
according to Kristiansen et al. [ 151. The aberrant 
crypts were identified by their increased size, the 
thicker and more deeply stained epithelial lining, 
and the increased pericryptal zone compared with nor- 
mal crypts [ 161. An ACF may consist of one to several 
crypts and in all three studies the ACF were grouped 
into small (l-3 crypts), medium (4-6 crypts), large 
(7-9 crypts) or extra-large (210 crypts). The experi- 
mental conditions have earlier been described in detail 
[8,13,14]. 
Study nos. 1 and 2 included wild-type mice as well 
as transgenic ET-pim-1 male and female mice, and 
ACF were observed in all IQ- and PhIP-treated 
mice, wild-type as well as transgenic. As the short- 
Study 
no. 
Mouse strain Sex Treatment Treatment period (weeks)/ 
Duration (weeks) 
References 
1 C57BL/6ByA F +0.03% PhIP in the diet 31/31 or up to 78 [13,141 
2 C57BLl6ByA F k&03% IQ in the diet 24140 u31 
3 C57BL/6J F M.03% PhIP or IQ in the diet 4 and 10 181 
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Table 2 
Effect of IQ on ACF-formation in female C57BL/6J (Study 3) and C57BL/6ByA (Study 2) mice 
Study No. of Duration ACF/ColoxPb 
no. mice (weeks) 
Small Medium Large Extra-large 
189 
Total 
3 4 4 31.7 2 5.2 0.3 * 0.3 0 0 32.0 Z!I 5.4 
3 10 10 71.2 z!z 4.2’** 0.2 + 0.1 0 0 71.4 * 4.1c** 
2 18 40 120.7 + 10.2d*** 5.6 f l.lcd*** 0.1 0.1 f 0.1 * 0.1 126.5 f 10.6d*** 
“Values are means + SE. 
bSmall foci, 1-3 crypts; medium foci, 4-6 crypts; large foci, 7-9 crypts; extra-large, 210 crypts. 
‘Differs from 4 weeks treatment. 
dDiffers from 10 weeks treatment. Wilcoxon rank-sum test. 
term study (study no. 3) solely was performed on 
wild-type female mice, only ACF-data from female 
wild-type mice from study nos. 1 and 2 were used 
together with data from study no. 3 to compare the 
ACF-incidences over time. 
W ilcoxon two-sample rank-sum test was used to 
analyze the number and distribution of ACF. A  prob- 
ability of I 5% was considered significant. All statis- 
tical calculations were carried out using SAS release 
6.11. 
3. Results 
3.1. No acf were detected in control animals 
The results for IQ-dosed animals are presented in 
Table 2. A  significant increase in number of small, 
medium and total number of ACF were seen over 
time. At all time-points small ACF (AC: l-3) 
accounted for almost alI of the ACF (99, 99, and 
95%, respectively). No tumors were found in the 
colons of mice with ACF, and only a few lung and 
liver tumors were found [ 131, which are in accordance 
with the literature [ 111. 
In Fig. 1, the number of ACF found in PhIP- 
induced mice during the studies is illustrated. In 
study no. 1, in which mice were sacrificed at two 
scheduled time-points, the mice died during the 
study as well. All PhIP-induced mice had ACF in 
their colon. It appears from the illustration that the 
induction of ACF increased until the exposure 
stopped. The number of induced ACF was still high 
shortly after termination of the exposure, but then it 
decreased. After 64 weeks the mean number increased 
but the data were based on very few mice and the 
increase at the terminal sacrifice (four mice) had a 
rather high standard error (mean + SE = 12.0 + 8.1). 
In Table 3 the results for PhIP are presented. In this 
table the PhIP-induced ACF data from study no. 1 are 
pooled. Even though the data from study no. 1 are 
obtained at different time-points they are compiled 
in the table, just to give an impression of what is 
happening with PhIP-induced ACF over time. A  sig- 
nificant increase in number of small, medium and total 
number of ACF was seen over time. At all three time- 
points small ACF accounted for almost all of the ACF 
(100, 100, and 96%, respectively). No colonic tumors 
were found in any of the PhIP-induced mice in study 
no. 1, but the study confirmed that PhIP is a potent 
mouse lymphomagen [12] as 70% of the wild-type 
mice, females as well as males, developed lymphomas 
u41. 
4. Discussion 
The present experiments showed that IQ and PhIP 
are able to induce ACF in mice, and that the number 
of small, medium, and total ACF increased statisti- 
cally sigr&cantly over time. IQ induced ACF in a 
much higher number than PhIP. Almost all ACF 
induced at all time-points were small ACF (95- 
100%). No tumors were induced in mouse colons by 
the two compounds. Likewise, other PhIP-studies per- 
formed with wild-type mice of strain Balb C (unpub- 
lished data) and transgenic Apcl638N mice [ 171 in our 
laboratory have shown an induction of ACE in PhIP- 
treated colons. 
It has been demonstrated in the literature that ACF 
are markers for development of colon cancer [7], and 
ACF have been suggested to be biologically hetero- 
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281’ 44 701s 185 218. Doseend 248 252 304 363 452 554. 
Experimental period in days. 
*Mean ACF of 4 mice. $Mean ACF of 10 mice 
Fig. 1. Aberrant crypt foci in colons from C57BL/6ByA and C57BL/6J# female mice given 0.03% PhIP in the diet up to 218 days and 
followed until death. 
geneous lesions where only a subpopulation persists ACF in the colon is not known. Unchanged IQ is 
and develops into cancer [ 181. In addition, the pre- known to be present in the gut of mice after oral 
sence of a high number of ACF with high crypt multi- administration [22]. Activation of such IQ to a 
plicity has been hypothesized to be predictive for direct-acting genotoxin by the colonic microflora 
tumor outcome [19-211. may thus lead to DNA damage in the colonic mucosa. 
The mechanism behind IQ and PhIP induction of The lack of accordance between the induction of 
Table 3 
Effect of PhIP on ACF-formation in female C57BL/6J (Study 3) and C57BL/6ByA (Study 1) mice 
Study 
no. 
No. of 
mice 
Duration 
(weeks) 
ACF/Colon”b 
Small Medium Large Extra- 
large 
Total 
3 4 4 0.5 f 0.3 0 0 0 0.5 It 0.3 
3 10 10 3.7 f l.od** 0 0 0 71.4 f 1.od** 
2 15 up to 78’ 0.5 + 2.8e*** 0 . 5 f 0 . p*** 0 0 14.0 f 2.ge*** 
aValues are means f SE. 
bSmall foci, l-3 crypts; medium foci, 4-6 crypts; large foci, 7-9 cqpts; extra-large, HO crypts. 
‘Pooled data, see Fig. 1. 
dDiffers from 4 weeks treatment. 
‘Differs from 10 weeks treatment. Wilcoxon rank-sum test. 
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ACF with PhIP and IQ and the development of tumors 
in carcinogenicity studies in mice [ 11,121, suggests 
that the ACF induced by these two chemicals do not 
represent an early stage of colon cancer. One explana- 
tion might be that PhIP and IQ are only weakly carci- 
nogenic to the colon compared to other organs, and 
therefore tumors arise in the liver, forestomach and 
lung in the case of IQ [ 111, and in the lymphoid tissue 
in the case of PhIP [12] long before they develop in 
the colon. Another explanation might be that the pre- 
sent results support the hypothesis that only the pre- 
sence of a high number of ACF with high crypt 
multiplicity is predictive for tumor outcome [19]-. 
[21]. In both the IQ- and the PhIP-studies almost all 
ACF induced at all time-points were small ACF. 
Finally, the possibility that IQ and PhIP are only 
weak initiators of colon cancer which must be fol- 
lowed by a promotor for the induced ACF to develop 
into colonic tumors in mice needs to be investigated. 
Another in vivo bioassay for detection of colon 
carcinogens is the nuclear aberration (NA) assay. 
The basis for this assay is that colon carcinogens, 
when given to mice, induce nuclear aberrations (i.e. 
micronuclei, karyorrhexis, and pyknosis (apoptotic 
bodies)) in colon crypts. In this NA assay, IQ in single 
doses of 200-800 mg/kg has been found to be a potent 
inducer of NA [23,24]. As nuclear aberrations are 
cell-lethal events, the induction of NA suggests that 
IQ, or its active metabolite, is capable of reaching the 
colonic epithelium and exerting nucleotoxic effects. 
Two other examples of non-colon carcinogens which 
both induce ACF and NA in mice colon are DMBA 
(7,12dimethylbenz(a)anthracene) and 
benzo(a)pyrene [9,25]. 
Even though abundant literature is available con- 
cerning ACF as an early marker for colon cancer, 
some investigations have failed to show correlation 
between ACF and colon cancer in mice. In a study 
by Carter et al. [26] using DMH-induced mice, the 
authors concluded that the total number of ACF is 
not necessarily a valid indicator of the overall risk 
of overt tumor formation, and proposed that ACF 
have little if any malignant potential in the mouse. 
Likewise, Steele and Kelloff [27] testing 42 chemo- 
preventive agents found that all of the false positive 
data (positive crypt/negative tumor) were derived 
from mouse tumor studies and the authors indicated 
that some species differences may exist. 
In conclusion, the present results suggest, that the 
detection of a high number of aberrant crypt foci with 
low crypt multiplicity (l-3 AC/Focus) in mice colon 
after IQ- or PhIP-treatment is not indicative for the 
end-point colon cancer. In this way the results confnm 
the stated hypothesis that only the presence of a high 
number of ACF with high crypt multiplicity is predic- 
tive for tumor outcome [ 19]-[21]. Therefore, the pre- 
sent study illustrates that, to avoid false prediction of 
colon cancer potential in screening procedures, this 
hypothesis needs to be further investigated. 
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